AlfonsoDex的个人主页 - 老虎社区

AlfonsoDex

AlfonsoDex

I am both a long-term investor and enthusiastic trader.

IP属地：未知

140关注

6粉丝

0主题

0勋章

2022-01-08

Oh

3 COVID Stocks That Will Make Billions in 2022<blockquote>2022年将赚取数十亿美元的3只COVID股票</blockquote>

2022-01-08

Ok

抱歉，原内容已删除

2022-01-08

Wow I see ok!

抱歉，原内容已删除

2022-01-07

Wow!

WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%<blockquote>WSB股价早盘暴跌，Micovision下跌近12%，AMC下跌超过6%</blockquote>

2022-01-01

Yes

抱歉，原内容已删除

2022-01-01

Ok

抱歉，原内容已删除

2022-01-01

Yes of course!

抱歉，原内容已删除

2021-12-29

[smile]

抱歉，原内容已删除

2021-12-29

Slow and steady !

Singapore Stock Market Called Rangebound For Wednesday<blockquote>新加坡股市周三区间震荡</blockquote>

2021-12-27

Yes this is a big concern... hope all go well eventually

外媒头条：奥密克戎重挫航空旅行！周日数千个航班被取消

2021-12-26

👍

抱歉，原内容已删除

2021-12-25

Good

抱歉，原内容已删除

2021-12-25

Ok

抱歉，原内容已删除

2021-12-25

Informative!

抱歉，原内容已删除

2021-12-19

Ok great!

抱歉，原内容已删除

2021-12-19

👍

抱歉，原内容已删除

2021-12-18

Hope all goes well moving into 2022.

2021-12-15

$Takeda Pharmaceutical Co Ltd(TAK)$Come on TAK... You possess good potential.. Up!

2021-12-14

Awesome

抱歉，原内容已删除

2021-12-05

$iSpecimen Inc.(ISPC)$rise again please....

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4098943201642940","uuid":"4098943201642940","gmtCreate":1635844622595,"gmtModify":1746497838354,"name":"AlfonsoDex","pinyin":"alfonsodex","introduction":"","introductionEn":"","signature":"I am both a long-term investor and enthusiastic trader.","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":140,"tweetSize":26,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.13","exceedPercentage":"80.27%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"02aa7f16703b4ce4ace6f1a7665789cc-2","templateUuid":"02aa7f16703b4ce4ace6f1a7665789cc","name":"知识探索家","description":"观看学堂课程满20节","bigImgUrl":"https://static.tigerbbs.com/63cc10a4789c3eaa019b225a55136cf9","smallImgUrl":"https://static.tigerbbs.com/b1f0cbf3ae1b0a4593ddb3434df74ce0","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.20","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":2006},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.05","exceedPercentage":"93.64%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":6,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":695745165,"gmtCreate":1641629120965,"gmtModify":1641629121332,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/695745165","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://www.laohu8.com/m/news/1134509683?lang=zh_CN&edition=full","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022<blockquote>2022年将赚取数十亿美元的3只COVID股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<p><html><head></head><body>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><blockquote><html><head></head><body>这是新的一年，新冠肺炎仍然和我们在一起。去年，我们看到医疗保健领域多种新冠疫苗和治疗方法获得了紧急使用授权。制药公司将在2022年赚取数十亿美元。以下是三只应该蓬勃发展的股票。</body></html></blockquote></p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p><blockquote><b>辉瑞</b>（纽约证券交易所股票代码：PFE）是一家价值3100亿美元的大型公司，预计其新冠疫苗和抗病毒药物的销售额将不会是10亿或100亿美元，而是超过500亿美元。斗志昂扬<b>Novavax</b>（纳斯达克：NVAX）终于在全球范围内推出了新冠疫苗。它将获得多少亿？我们有一个黑马候选人<b>维尔生物技术</b>（纳斯达克：维尔）。对于这家小型生物技术公司来说，它的一种药物很容易成为价值10亿美元的重磅炸弹。</blockquote></p><p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p><b>A safe harbor in stormy weather</b></p><p><blockquote><b>暴风雨天气中的避风港</b></blockquote></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p><blockquote><b>乔治·巴德威尔（辉瑞）：</b>辉瑞是新冠肺炎制药产品无可争议的冠军。仅在2022年，华尔街预计这家制药巨头的新型冠状病毒疫苗Comirnaty和口服抗病毒药物Paxlovid的销售额就将达到550亿美元。</blockquote></p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p><blockquote>更重要的是，分析师开始接受Paxlovid可能在当前十年内成为该公司可持续收入来源的想法。当该药物上个月首次被美国食品和药物管理局根据紧急使用授权途径允许上市时，华尔街认为从商业角度来看，Paxlovid可能会在一年左右的时间内达到顶峰，然后随着疫情从视野中消失，销售额急剧下降。</blockquote></p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p><blockquote>但距离该药物首次获得批准还不到三周，令人痛苦的是，很明显，Paxlovid可能需要作为未来几年COVID-19最坏结果的故障保险。毕竟，高传染性的奥密克戎变种肯定不会是该病毒的最后一次重大迭代。</blockquote></p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p><blockquote>这一切意味着，辉瑞应该是少数几家在新冠肺炎拥有可观、长期收入来源的大型制药商之一。反过来，在可预见的未来，辉瑞应该有充足的自由现金流来满足其慷慨的股东奖励计划以及雄心勃勃的业务发展计划。</blockquote></p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><blockquote>因此，如果您正在寻找一只能够抵御极高通胀和利率上升双重阻力的股票，辉瑞可能值得一试。</blockquote></p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><blockquote><b>Novavax的收入预测：20亿至80亿美元</b></blockquote></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p><blockquote><b>泰勒·卡迈克尔（Novavax）：</b>Novavax今年正处于伟大的边缘。该公司的股价跌至每股125美元。这就是它在2021年开始的地方，所以去年该股几乎遭受了洗盘。</blockquote></p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p><blockquote>早在2月份，当Novavax报告其新冠疫苗的积极3期数据时，股价就飙升至300美元以上。但后来这家小型生物技术公司遇到了制造问题。虽然许多人说它的疫苗是同类产品中最好的，但扩大约20亿剂疫苗的合同生产说起来容易做起来难。这些现实导致该股较高点下跌约60%。</blockquote></p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p><blockquote>尽管如此，Novavax的收入已经达到了10亿美元大关，因此由于所有的预订，其疫苗甚至在获得批准之前就已经一鸣惊人。现在，全球各地的授权纷至沓来，Novavax很有可能在2022年运送大量疫苗。该公司已经实现了每月1亿剂的生产能力，即一年12亿剂。在第三季度收益看涨期权上，管理层预测到第四季度末将达到每月1.5亿剂（或每年18亿剂）的生产能力。该公司预计将继续扩大规模，并预测2022年将分发20亿剂疫苗。</blockquote></p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p><blockquote>20亿剂疫苗，价格为16美元（曲速行动支付了16亿美元预购了1亿剂疫苗），我们粗略计算出收入为320亿美元。当然，Novavax将以较低的速度向发展中国家分发大量疫苗。尽管该公司对其价格保持沉默，但丹麦早在8月份就表示，根据欧盟(EU)协议，它为每剂疫苗支付了近21美元。欧盟已经订购了2亿剂，因此仅在欧洲的销售额就超过40亿美元。</blockquote></p><p></p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><blockquote>分析师非常保守，对Novavax 2022年的预测在20亿至80亿美元之间。（该公司的市值为90亿美元。）虽然一路上可能会出现一些问题，但Novavax肯定会在2022年从其COVID-19疫苗中赚取数十亿美元。如果该公司确实像其所说的那样交付20亿剂疫苗，该股可能会有大幅上涨空间。</blockquote></p><p><b>The antibody market all to itself</b></p><p><blockquote><b>抗体市场全靠自己</b></blockquote></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p><blockquote><b>Patrick Bafuma（Vir Biotechnology）：</b>奥密克戎变种目前猖獗，这一次，我们缺少一些治疗方法。以前青睐的单克隆抗体治疗来自<b>礼来公司</b>（bamlanivimab加etesevimab）以及来自<b>罗氏</b>和<b>再生</b>被认为对当前变体的活性显著降低。这样就只剩下一种对奥密克戎有效的输液了--<b>葛兰素史克</b>以及Vir Biotechnology的sotrovimab。这种单克隆抗体先前证明，在轻度至中度新冠肺炎和进展为重度疾病的高风险成人中，住院和死亡风险降低了79%。它是目前唯一一个对抗奥密克戎变种的人。</blockquote></p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p><blockquote>作为唯一的单克隆抗体将有其特权。2021年前9个月，REGEN-COV带来了35亿美元的产品净销售额，而礼来公司的抗体组合带来了11.7亿美元。美国政府已经签订了价值约10亿美元的sotrovimab合同。随着医院挤满了病人，任何有助于缓解系统压力的东西都可能受到高度追捧。</blockquote></p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p><p><blockquote>虽然辉瑞的Paxlovid将极大地有利于减轻医疗保健系统的COVID-19负担，但这种口服药物具有显着且复杂的药物相互作用潜力。事实上，它的相互作用列表读起来就像是常用处方药的名人录。这包括流行的血液稀释剂，如波立维和Xarelto，常见的止痛药，如曲马多和羟考酮，抗焦虑药，如Klonopin和Xanax，以及抗胆固醇他汀类药物。随着美国国立卫生研究院发表声明，表达了对Paxlovid可能的药物相互作用的担忧，这为sotrovimab继续广泛使用留下了充足的空间。根据与GSK的协议，Vir获得了sotrovimab销售额的72.5%，这家价值44亿美元的生物技术公司目前看起来很划算。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022<blockquote>2022年将赚取数十亿美元的3只COVID股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022<blockquote>2022年将赚取数十亿美元的3只COVID股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2022-01-08 11:29</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><blockquote><html><head></head><body>这是新的一年，新冠肺炎仍然和我们在一起。去年，我们看到医疗保健领域多种新冠疫苗和治疗方法获得了紧急使用授权。制药公司将在2022年赚取数十亿美元。以下是三只应该蓬勃发展的股票。</body></html></blockquote></p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p><blockquote><b>辉瑞</b>（纽约证券交易所股票代码：PFE）是一家价值3100亿美元的大型公司，预计其新冠疫苗和抗病毒药物的销售额将不会是10亿或100亿美元，而是超过500亿美元。斗志昂扬<b>Novavax</b>（纳斯达克：NVAX）终于在全球范围内推出了新冠疫苗。它将获得多少亿？我们有一个黑马候选人<b>维尔生物技术</b>（纳斯达克：维尔）。对于这家小型生物技术公司来说，它的一种药物很容易成为价值10亿美元的重磅炸弹。</blockquote></p><p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p><b>A safe harbor in stormy weather</b></p><p><blockquote><b>暴风雨天气中的避风港</b></blockquote></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p><blockquote><b>乔治·巴德威尔（辉瑞）：</b>辉瑞是新冠肺炎制药产品无可争议的冠军。仅在2022年，华尔街预计这家制药巨头的新型冠状病毒疫苗Comirnaty和口服抗病毒药物Paxlovid的销售额就将达到550亿美元。</blockquote></p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p><blockquote>更重要的是，分析师开始接受Paxlovid可能在当前十年内成为该公司可持续收入来源的想法。当该药物上个月首次被美国食品和药物管理局根据紧急使用授权途径允许上市时，华尔街认为从商业角度来看，Paxlovid可能会在一年左右的时间内达到顶峰，然后随着疫情从视野中消失，销售额急剧下降。</blockquote></p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p><blockquote>但距离该药物首次获得批准还不到三周，令人痛苦的是，很明显，Paxlovid可能需要作为未来几年COVID-19最坏结果的故障保险。毕竟，高传染性的奥密克戎变种肯定不会是该病毒的最后一次重大迭代。</blockquote></p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p><blockquote>这一切意味着，辉瑞应该是少数几家在新冠肺炎拥有可观、长期收入来源的大型制药商之一。反过来，在可预见的未来，辉瑞应该有充足的自由现金流来满足其慷慨的股东奖励计划以及雄心勃勃的业务发展计划。</blockquote></p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><blockquote>因此，如果您正在寻找一只能够抵御极高通胀和利率上升双重阻力的股票，辉瑞可能值得一试。</blockquote></p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><blockquote><b>Novavax的收入预测：20亿至80亿美元</b></blockquote></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p><blockquote><b>泰勒·卡迈克尔（Novavax）：</b>Novavax今年正处于伟大的边缘。该公司的股价跌至每股125美元。这就是它在2021年开始的地方，所以去年该股几乎遭受了洗盘。</blockquote></p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p><blockquote>早在2月份，当Novavax报告其新冠疫苗的积极3期数据时，股价就飙升至300美元以上。但后来这家小型生物技术公司遇到了制造问题。虽然许多人说它的疫苗是同类产品中最好的，但扩大约20亿剂疫苗的合同生产说起来容易做起来难。这些现实导致该股较高点下跌约60%。</blockquote></p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p><blockquote>尽管如此，Novavax的收入已经达到了10亿美元大关，因此由于所有的预订，其疫苗甚至在获得批准之前就已经一鸣惊人。现在，全球各地的授权纷至沓来，Novavax很有可能在2022年运送大量疫苗。该公司已经实现了每月1亿剂的生产能力，即一年12亿剂。在第三季度收益看涨期权上，管理层预测到第四季度末将达到每月1.5亿剂（或每年18亿剂）的生产能力。该公司预计将继续扩大规模，并预测2022年将分发20亿剂疫苗。</blockquote></p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p><blockquote>20亿剂疫苗，价格为16美元（曲速行动支付了16亿美元预购了1亿剂疫苗），我们粗略计算出收入为320亿美元。当然，Novavax将以较低的速度向发展中国家分发大量疫苗。尽管该公司对其价格保持沉默，但丹麦早在8月份就表示，根据欧盟(EU)协议，它为每剂疫苗支付了近21美元。欧盟已经订购了2亿剂，因此仅在欧洲的销售额就超过40亿美元。</blockquote></p><p></p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><blockquote>分析师非常保守，对Novavax 2022年的预测在20亿至80亿美元之间。（该公司的市值为90亿美元。）虽然一路上可能会出现一些问题，但Novavax肯定会在2022年从其COVID-19疫苗中赚取数十亿美元。如果该公司确实像其所说的那样交付20亿剂疫苗，该股可能会有大幅上涨空间。</blockquote></p><p><b>The antibody market all to itself</b></p><p><blockquote><b>抗体市场全靠自己</b></blockquote></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p><blockquote><b>Patrick Bafuma（Vir Biotechnology）：</b>奥密克戎变种目前猖獗，这一次，我们缺少一些治疗方法。以前青睐的单克隆抗体治疗来自<b>礼来公司</b>（bamlanivimab加etesevimab）以及来自<b>罗氏</b>和<b>再生</b>被认为对当前变体的活性显著降低。这样就只剩下一种对奥密克戎有效的输液了--<b>葛兰素史克</b>以及Vir Biotechnology的sotrovimab。这种单克隆抗体先前证明，在轻度至中度新冠肺炎和进展为重度疾病的高风险成人中，住院和死亡风险降低了79%。它是目前唯一一个对抗奥密克戎变种的人。</blockquote></p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p><blockquote>作为唯一的单克隆抗体将有其特权。2021年前9个月，REGEN-COV带来了35亿美元的产品净销售额，而礼来公司的抗体组合带来了11.7亿美元。美国政府已经签订了价值约10亿美元的sotrovimab合同。随着医院挤满了病人，任何有助于缓解系统压力的东西都可能受到高度追捧。</blockquote></p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p><p><blockquote>虽然辉瑞的Paxlovid将极大地有利于减轻医疗保健系统的COVID-19负担，但这种口服药物具有显着且复杂的药物相互作用潜力。事实上，它的相互作用列表读起来就像是常用处方药的名人录。这包括流行的血液稀释剂，如波立维和Xarelto，常见的止痛药，如曲马多和羟考酮，抗焦虑药，如Klonopin和Xanax，以及抗胆固醇他汀类药物。随着美国国立卫生研究院发表声明，表达了对Paxlovid可能的药物相互作用的担忧，这为sotrovimab继续广泛使用留下了充足的空间。根据与GSK的协议，Vir获得了sotrovimab销售额的72.5%，这家价值44亿美元的生物技术公司目前看起来很划算。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc.","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1,"symbols_score_info":{"VIR":0.9,"PFE":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":695784179,"gmtCreate":1641601095402,"gmtModify":1641601095859,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/695784179","repostId":"2201216295","repostType":4,"isVote":1,"tweetType":1,"viewCount":2632,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":695784326,"gmtCreate":1641601075110,"gmtModify":1641601075405,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Wow I see ok!","listText":"Wow I see ok!","text":"Wow I see ok!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/695784326","repostId":"2201216295","repostType":4,"isVote":1,"tweetType":1,"viewCount":3216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":695596823,"gmtCreate":1641510812466,"gmtModify":1641510812589,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Wow!","listText":"Wow!","text":"Wow!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/695596823","repostId":"1166118266","repostType":4,"repost":{"id":"1166118266","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641482074,"share":"https://www.laohu8.com/m/news/1166118266?lang=zh_CN&edition=full","pubTime":"2022-01-06 23:14","market":"us","language":"en","title":"WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%<blockquote>WSB股价早盘暴跌，Micovision下跌近12%，AMC下跌超过6%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1166118266","media":"Tiger Newspress","summary":"WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%.","content":"<p><html><head></head><body>WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%.<img src=\"https://static.tigerbbs.com/c60f40de514ea1491fcc1b628923f44f\" tg-width=\"282\" tg-height=\"435\" referrerpolicy=\"no-referrer\"/>On Wednesday, the Federal Reserve released minutes from its December meeting. While officials had already announced a tapering of bond purchases and expectations for several rate hikes this year, the minutes revealed the possibility for even more aggressive moves. Several officials thought the Fed could shrink its balance sheet of Treasuries and mortgage-backed assets, which it has been buying for some time to nurse the economy back to health. Tapering asset purchases merely suggested the Fed would be buying fewer securities but would still be purchasing. Letting the balance sheet shrink would be an indicator of even tighter financial conditions than that.</p><p><blockquote><html><head></head><body>WSB股价早盘暴跌，Micovision下跌近12%，AMC下跌超过6%。周三，美联储公布了12月会议纪要。尽管官员们已经宣布缩减购债规模，并预计今年将多次加息，但会议纪要显示，可能会采取更激进的举措。几位官员认为，美联储可能会缩减其国债和抵押贷款支持资产的资产负债表，美联储购买这些资产已经有一段时间了，以帮助经济恢复健康。缩减资产购买只是表明美联储将减少购买证券，但仍将继续购买。让资产负债表收缩将表明金融状况比这更紧张。</body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%<blockquote>WSB股价早盘暴跌，Micovision下跌近12%，AMC下跌超过6%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%<blockquote>WSB股价早盘暴跌，Micovision下跌近12%，AMC下跌超过6%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2022-01-06 23:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%.<img src=\"https://static.tigerbbs.com/c60f40de514ea1491fcc1b628923f44f\" tg-width=\"282\" tg-height=\"435\" referrerpolicy=\"no-referrer\"/>On Wednesday, the Federal Reserve released minutes from its December meeting. While officials had already announced a tapering of bond purchases and expectations for several rate hikes this year, the minutes revealed the possibility for even more aggressive moves. Several officials thought the Fed could shrink its balance sheet of Treasuries and mortgage-backed assets, which it has been buying for some time to nurse the economy back to health. Tapering asset purchases merely suggested the Fed would be buying fewer securities but would still be purchasing. Letting the balance sheet shrink would be an indicator of even tighter financial conditions than that.</p><p><blockquote><html><head></head><body>WSB股价早盘暴跌，Micovision下跌近12%，AMC下跌超过6%。周三，美联储公布了12月会议纪要。尽管官员们已经宣布缩减购债规模，并预计今年将多次加息，但会议纪要显示，可能会采取更激进的举措。几位官员认为，美联储可能会缩减其国债和抵押贷款支持资产的资产负债表，美联储购买这些资产已经有一段时间了，以帮助经济恢复健康。缩减资产购买只是表明美联储将减少购买证券，但仍将继续购买。让资产负债表收缩将表明金融状况比这更紧张。</body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","MVIS":"维视图像"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166118266","content_text":"WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%.On Wednesday, the Federal Reserve released minutes from its December meeting. While officials had already announced a tapering of bond purchases and expectations for several rate hikes this year, the minutes revealed the possibility for even more aggressive moves. Several officials thought the Fed could shrink its balance sheet of Treasuries and mortgage-backed assets, which it has been buying for some time to nurse the economy back to health. Tapering asset purchases merely suggested the Fed would be buying fewer securities but would still be purchasing. Letting the balance sheet shrink would be an indicator of even tighter financial conditions than that.","news_type":1,"symbols_score_info":{"MVIS":0.9,"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":2769,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692248164,"gmtCreate":1641007210279,"gmtModify":1641007334497,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692248164","repostId":"2200744536","repostType":4,"isVote":1,"tweetType":1,"viewCount":3230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692248347,"gmtCreate":1641007195112,"gmtModify":1641007334405,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692248347","repostId":"1114332157","repostType":4,"isVote":1,"tweetType":1,"viewCount":4452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692241460,"gmtCreate":1641007146854,"gmtModify":1641007273977,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Yes of course!","listText":"Yes of course!","text":"Yes of course!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/692241460","repostId":"2195448557","repostType":4,"isVote":1,"tweetType":1,"viewCount":2966,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696522867,"gmtCreate":1640738222192,"gmtModify":1640738401567,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"[smile]&nbsp;","listText":"[smile]&nbsp;","text":"[smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696522867","repostId":"1163970983","repostType":4,"isVote":1,"tweetType":1,"viewCount":3723,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696522373,"gmtCreate":1640738199041,"gmtModify":1640738401450,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Slow and steady !","listText":"Slow and steady !","text":"Slow and steady !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/696522373","repostId":"1113618075","repostType":4,"repost":{"id":"1113618075","kind":"news","pubTimestamp":1640736836,"share":"https://www.laohu8.com/m/news/1113618075?lang=zh_CN&edition=full","pubTime":"2021-12-29 08:13","market":"sg","language":"en","title":"Singapore Stock Market Called Rangebound For Wednesday<blockquote>新加坡股市周三区间震荡</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1113618075","media":"RTTNews","summary":"The Singapore stock market rebounded on Tuesday, one session after snapping the four-day winning str","content":"<p>The Singapore stock market rebounded on Tuesday, one session after snapping the four-day winning streak in which it had gathered almost 35 points or 1.2 percent. The Straits Times Index now sits just beneath the 3,130-point plateau and it's expected to remain in that neighborhood again on Wednesday.</p><p><blockquote>新加坡股市周二反弹，此前一个交易日结束了连续四天上涨近35点或1.2%。海峡时报指数目前略低于3,130点的高位，预计周三将再次保持在该附近。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is mixed, with support expected from oil companies and weakness likely from tech shares. The European and U.S. markets were mixed and the Asian bourses figure to follow suit.</p><p><blockquote>全球对亚洲市场的预测好坏参半，预计石油公司将提供支撑，科技股可能疲软。欧洲和美国市场涨跌互现，亚洲股市也将效仿。</blockquote></p><p> The STI finished modestly higher on Tuesday following gains from the financial shares, property stocks and industrial issues.</p><p><blockquote>继金融股、房地产股和工业股上涨后，海指周二小幅收高。</blockquote></p><p> For the day, the index collected 24.17 points or 0.78 percent to finish at 3,128.41 after trading between 3,108.93 and 3,128.92. Volume was 975.3 million shares worth 489.9 million Singapore dollars. There were 290 gainers and 175 decliners.</p><p><blockquote>当天，该指数在3,108.93至3,128.92之间交易后，上涨24.17点或0.78%，收于3,128.41点。成交量为9.753亿股，价值4.899亿新元。上涨股290股，下跌股175股。</blockquote></p><p> Among the actives, Ascendas REIT increased 0.68 percent, CapitaLand Integrated Commercial Trust soared 1.50 percent, City Developments advanced 0.89 percent, Comfort DelGro accelerated 1.45 percent, Dairy Farm International surged 3.57 percent, DBS Group rose 0.77 percent, Genting Singapore improved 0.65 percent, Keppel Corp perked 0.98 percent, Mapletree Logistics Trust strengthened 0.54 percent, Oversea-Chinese Banking Corporation added 0.88 percent, SATS jumped 1.30 percent, SembCorp Industries was up 0.50 percent, Singapore Airlines gathered 1.01 percent, Singapore Exchange gained 0.86 percent, Singapore Technologies Engineering climbed 1.08 percent, SingTel rallied 1.29 percent, Thai Beverage lost 0.75 percent, United Overseas Bank collected 0.64 percent, Wilmar International spiked 1.47 percent and Yangzijiang Shipbuilding, Mapletree Commercial Trust and Singapore Press Holdings were unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托上涨0.68%，凯德综合商业信托飙升1.50%，City Developments上涨0.89%，Comfort DelGro加速上涨1.45%，Dairy Farm International飙升3.57%，星展集团上涨0.77%，云顶新加坡上涨0.65%，吉宝企业上涨0.98%，丰树物流信托上涨0.54%，华侨银行上涨0.88%，胜科工业上涨0.50%，新加坡航空上涨1.01%，新加坡交易所上涨0.86%，新加坡科技工程上涨1.08%，新加坡电信上涨1.29%，泰国饮料下跌0.75%，丰益国际上涨1.47%，扬子江造船、丰树商业信托和新加坡报业控股持平。</blockquote></p><p> The lead from Wall Street is mixed as the Dow opened higher on Thursday and stayed that way, the S&amp;P 500 opened higher but gradually fell into the red and the NASDAQ simply spent most of the day in negative territory.</p><p><blockquote>华尔街的领先优势好坏参半，道琼斯指数周四高开并保持这种状态，标普500高开但逐渐陷入亏损，纳斯达克则全天大部分时间都处于负值区域。</blockquote></p><p> The Dow gained 95.83 points or 0.26 percent to finish at 36,398.21, while the NASDAQ sank 89.54 points or 0.56 percent to close at 15,781.72 and the S&amp;P 500 eased 4.84 points or 0.10 percent to end at 4,786.35.</p><p><blockquote>道琼斯指数上涨95.83点或0.26%，收于36,398.21点；纳斯达克下跌89.54点或0.56%，收于15,781.72点；标普500下跌4.84点或0.10%，收于4,786.35点。</blockquote></p><p> The lackluster performance came as traders were reluctant to continue making significant moves following the recent strength in the markets. But they largely refrained from cashing in on recent gains amid easing concerns about the impact of the Omicron variant of the&nbsp;coronavirus.</p><p><blockquote>由于近期市场走强后，交易员不愿继续采取重大举措，因此表现低迷。但由于对冠状病毒奥密克戎变种影响的担忧有所缓解，他们基本上没有兑现近期的涨幅。</blockquote></p><p> Helping offset worries about the pandemic, the Centers for Disease Control and Prevention has shortened the recommended isolation time to for asymptomatic people with Covid-19 to 5 days from 10 days.</p><p><blockquote>为了帮助抵消对疫情的担忧，疾病控制和预防中心将无症状新冠肺炎患者的建议隔离时间从10天缩短到5天。</blockquote></p><p> Crude oil futures rose Tuesday, extending gains to a fifth straight session on hopes the Omicron variant of the coronavirus is unlikely to impact global economic recovery. West Texas Intermediate Crude oil futures for February added $0.41 or 0.5 percent at $75.98 a barrel.</p><p><blockquote>原油期货周二上涨，连续第五个交易日上涨，因人们希望冠状病毒的奥密克戎变种不太可能影响全球经济复苏。西德克萨斯中质原油2月期货价格上涨0.41美元，或0.5%，报每桶75.98美元。</blockquote></p><p> Closer to home, Singapore will release November numbers for import, export and producer prices later today. In October, import prices rose 20.0 percent on year, while export prices jumped an annual 20.7 percent and producer prices spiked 25.4 percent.</p><p><blockquote>言归正传，新加坡将于今天晚些时候公布11月份的进口、出口和生产者价格数据。10月份，进口价格同比上涨20.0%，出口价格同比上涨20.7%，生产者价格飙升25.4%。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Stock Market Called Rangebound For Wednesday<blockquote>新加坡股市周三区间震荡</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Stock Market Called Rangebound For Wednesday<blockquote>新加坡股市周三区间震荡</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-29 08:13</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market rebounded on Tuesday, one session after snapping the four-day winning streak in which it had gathered almost 35 points or 1.2 percent. The Straits Times Index now sits just beneath the 3,130-point plateau and it's expected to remain in that neighborhood again on Wednesday.</p><p><blockquote>新加坡股市周二反弹，此前一个交易日结束了连续四天上涨近35点或1.2%。海峡时报指数目前略低于3,130点的高位，预计周三将再次保持在该附近。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is mixed, with support expected from oil companies and weakness likely from tech shares. The European and U.S. markets were mixed and the Asian bourses figure to follow suit.</p><p><blockquote>全球对亚洲市场的预测好坏参半，预计石油公司将提供支撑，科技股可能疲软。欧洲和美国市场涨跌互现，亚洲股市也将效仿。</blockquote></p><p> The STI finished modestly higher on Tuesday following gains from the financial shares, property stocks and industrial issues.</p><p><blockquote>继金融股、房地产股和工业股上涨后，海指周二小幅收高。</blockquote></p><p> For the day, the index collected 24.17 points or 0.78 percent to finish at 3,128.41 after trading between 3,108.93 and 3,128.92. Volume was 975.3 million shares worth 489.9 million Singapore dollars. There were 290 gainers and 175 decliners.</p><p><blockquote>当天，该指数在3,108.93至3,128.92之间交易后，上涨24.17点或0.78%，收于3,128.41点。成交量为9.753亿股，价值4.899亿新元。上涨股290股，下跌股175股。</blockquote></p><p> Among the actives, Ascendas REIT increased 0.68 percent, CapitaLand Integrated Commercial Trust soared 1.50 percent, City Developments advanced 0.89 percent, Comfort DelGro accelerated 1.45 percent, Dairy Farm International surged 3.57 percent, DBS Group rose 0.77 percent, Genting Singapore improved 0.65 percent, Keppel Corp perked 0.98 percent, Mapletree Logistics Trust strengthened 0.54 percent, Oversea-Chinese Banking Corporation added 0.88 percent, SATS jumped 1.30 percent, SembCorp Industries was up 0.50 percent, Singapore Airlines gathered 1.01 percent, Singapore Exchange gained 0.86 percent, Singapore Technologies Engineering climbed 1.08 percent, SingTel rallied 1.29 percent, Thai Beverage lost 0.75 percent, United Overseas Bank collected 0.64 percent, Wilmar International spiked 1.47 percent and Yangzijiang Shipbuilding, Mapletree Commercial Trust and Singapore Press Holdings were unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托上涨0.68%，凯德综合商业信托飙升1.50%，City Developments上涨0.89%，Comfort DelGro加速上涨1.45%，Dairy Farm International飙升3.57%，星展集团上涨0.77%，云顶新加坡上涨0.65%，吉宝企业上涨0.98%，丰树物流信托上涨0.54%，华侨银行上涨0.88%，胜科工业上涨0.50%，新加坡航空上涨1.01%，新加坡交易所上涨0.86%，新加坡科技工程上涨1.08%，新加坡电信上涨1.29%，泰国饮料下跌0.75%，丰益国际上涨1.47%，扬子江造船、丰树商业信托和新加坡报业控股持平。</blockquote></p><p> The lead from Wall Street is mixed as the Dow opened higher on Thursday and stayed that way, the S&amp;P 500 opened higher but gradually fell into the red and the NASDAQ simply spent most of the day in negative territory.</p><p><blockquote>华尔街的领先优势好坏参半，道琼斯指数周四高开并保持这种状态，标普500高开但逐渐陷入亏损，纳斯达克则全天大部分时间都处于负值区域。</blockquote></p><p> The Dow gained 95.83 points or 0.26 percent to finish at 36,398.21, while the NASDAQ sank 89.54 points or 0.56 percent to close at 15,781.72 and the S&amp;P 500 eased 4.84 points or 0.10 percent to end at 4,786.35.</p><p><blockquote>道琼斯指数上涨95.83点或0.26%，收于36,398.21点；纳斯达克下跌89.54点或0.56%，收于15,781.72点；标普500下跌4.84点或0.10%，收于4,786.35点。</blockquote></p><p> The lackluster performance came as traders were reluctant to continue making significant moves following the recent strength in the markets. But they largely refrained from cashing in on recent gains amid easing concerns about the impact of the Omicron variant of the&nbsp;coronavirus.</p><p><blockquote>由于近期市场走强后，交易员不愿继续采取重大举措，因此表现低迷。但由于对冠状病毒奥密克戎变种影响的担忧有所缓解，他们基本上没有兑现近期的涨幅。</blockquote></p><p> Helping offset worries about the pandemic, the Centers for Disease Control and Prevention has shortened the recommended isolation time to for asymptomatic people with Covid-19 to 5 days from 10 days.</p><p><blockquote>为了帮助抵消对疫情的担忧，疾病控制和预防中心将无症状新冠肺炎患者的建议隔离时间从10天缩短到5天。</blockquote></p><p> Crude oil futures rose Tuesday, extending gains to a fifth straight session on hopes the Omicron variant of the coronavirus is unlikely to impact global economic recovery. West Texas Intermediate Crude oil futures for February added $0.41 or 0.5 percent at $75.98 a barrel.</p><p><blockquote>原油期货周二上涨，连续第五个交易日上涨，因人们希望冠状病毒的奥密克戎变种不太可能影响全球经济复苏。西德克萨斯中质原油2月期货价格上涨0.41美元，或0.5%，报每桶75.98美元。</blockquote></p><p> Closer to home, Singapore will release November numbers for import, export and producer prices later today. In October, import prices rose 20.0 percent on year, while export prices jumped an annual 20.7 percent and producer prices spiked 25.4 percent.</p><p><blockquote>言归正传，新加坡将于今天晚些时候公布11月份的进口、出口和生产者价格数据。10月份，进口价格同比上涨20.0%，出口价格同比上涨20.7%，生产者价格飙升25.4%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3251796/singapore-stock-market-called-rangebound-for-wednesday.aspx?type=acom\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3251796/singapore-stock-market-called-rangebound-for-wednesday.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113618075","content_text":"The Singapore stock market rebounded on Tuesday, one session after snapping the four-day winning streak in which it had gathered almost 35 points or 1.2 percent. The Straits Times Index now sits just beneath the 3,130-point plateau and it's expected to remain in that neighborhood again on Wednesday.\nThe global forecast for the Asian markets is mixed, with support expected from oil companies and weakness likely from tech shares. The European and U.S. markets were mixed and the Asian bourses figure to follow suit.\nThe STI finished modestly higher on Tuesday following gains from the financial shares, property stocks and industrial issues.\nFor the day, the index collected 24.17 points or 0.78 percent to finish at 3,128.41 after trading between 3,108.93 and 3,128.92. Volume was 975.3 million shares worth 489.9 million Singapore dollars. There were 290 gainers and 175 decliners.\nAmong the actives, Ascendas REIT increased 0.68 percent, CapitaLand Integrated Commercial Trust soared 1.50 percent, City Developments advanced 0.89 percent, Comfort DelGro accelerated 1.45 percent, Dairy Farm International surged 3.57 percent, DBS Group rose 0.77 percent, Genting Singapore improved 0.65 percent, Keppel Corp perked 0.98 percent, Mapletree Logistics Trust strengthened 0.54 percent, Oversea-Chinese Banking Corporation added 0.88 percent, SATS jumped 1.30 percent, SembCorp Industries was up 0.50 percent, Singapore Airlines gathered 1.01 percent, Singapore Exchange gained 0.86 percent, Singapore Technologies Engineering climbed 1.08 percent, SingTel rallied 1.29 percent, Thai Beverage lost 0.75 percent, United Overseas Bank collected 0.64 percent, Wilmar International spiked 1.47 percent and Yangzijiang Shipbuilding, Mapletree Commercial Trust and Singapore Press Holdings were unchanged.\nThe lead from Wall Street is mixed as the Dow opened higher on Thursday and stayed that way, the S&P 500 opened higher but gradually fell into the red and the NASDAQ simply spent most of the day in negative territory.\nThe Dow gained 95.83 points or 0.26 percent to finish at 36,398.21, while the NASDAQ sank 89.54 points or 0.56 percent to close at 15,781.72 and the S&P 500 eased 4.84 points or 0.10 percent to end at 4,786.35.\nThe lackluster performance came as traders were reluctant to continue making significant moves following the recent strength in the markets. But they largely refrained from cashing in on recent gains amid easing concerns about the impact of the Omicron variant of the coronavirus.\nHelping offset worries about the pandemic, the Centers for Disease Control and Prevention has shortened the recommended isolation time to for asymptomatic people with Covid-19 to 5 days from 10 days.\nCrude oil futures rose Tuesday, extending gains to a fifth straight session on hopes the Omicron variant of the coronavirus is unlikely to impact global economic recovery. West Texas Intermediate Crude oil futures for February added $0.41 or 0.5 percent at $75.98 a barrel.\nCloser to home, Singapore will release November numbers for import, export and producer prices later today. In October, import prices rose 20.0 percent on year, while export prices jumped an annual 20.7 percent and producer prices spiked 25.4 percent.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":2929,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698746263,"gmtCreate":1640565094403,"gmtModify":1640565094496,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Yes this is a big concern... hope all go well eventually","listText":"Yes this is a big concern... hope all go well eventually","text":"Yes this is a big concern... hope all go well eventually","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698746263","repostId":"2194177763","repostType":2,"repost":{"id":"2194177763","kind":"highlight","pubTimestamp":1640555213,"share":"https://www.laohu8.com/m/news/2194177763?lang=zh_CN&edition=full","pubTime":"2021-12-27 05:46","market":"us","language":"zh","title":"外媒头条：奥密克戎重挫航空旅行！周日数千个航班被取消","url":"https://stock-news.laohu8.com/highlight/detail?id=2194177763","media":"市场资讯","summary":"　　周日，美国数百个航班和全球数千个航班被取消，原因是在今年最繁忙的一个周末，奥密克戎变种病毒导致机组人员患病。　　据提供航空数据的FlightAware称，截至周日中午，至少有一站在美国的750多个航班被取消，而全球航班的取消数字则是其10倍。　　周日的惨淡记录是在圣诞前夜和圣诞节期间全球数千次航班取消之后出现的。取消航班可能会打乱旅行计划，而此时许多人正乘飞机与家人共度圣诞假期。","content":"<p><b>全球财经媒体昨夜今晨共同关注的头条新闻主要有：</b></p>\n<blockquote>\n <b>1、奥密克戎重挫航空旅行 周日全球数千个航班被取消</b>\n</blockquote>\n<blockquote>\n <b>2、疫情下世界各国收紧新年庆典防疫政策 多地取消活动</b>\n</blockquote>\n<blockquote>\n <b>3、福奇警告美国人不要对病毒掉以轻心 医院有可能被挤爆</b>\n</blockquote>\n<blockquote>\n <b>4、英国智库：世界经济规模预计在明年超过100万亿美元</b>\n</blockquote>\n<blockquote>\n <b>5、土耳其颁布新措施救市 里拉短时间内大幅度反弹</b>\n</blockquote>\n<blockquote>\n <b>6、<a href=\"https://laohu8.com/S/MA\">万事达</a>报告称假日销售飙升 电子商务获得巨大收益</b>\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/c3ba1ba0a72a5c08f91ca9cb2fb61ccf\" tg-width=\"550\" tg-height=\"366\" referrerpolicy=\"no-referrer\"></p>\n<p><b>奥密克戎重挫航空旅行 周日全球数千个航班被取消</b></p>\n<p>周日，美国数百个航班和全球数千个航班被取消，原因是在今年最繁忙的一个周末，奥密克戎变种病毒导致机组人员患病。</p>\n<p>据提供航空数据的FlightAware称，截至周日中午，至少有一站在美国的750多个航班被取消，而全球航班的取消数字则是其10倍。</p>\n<p>周日的惨淡记录是在圣诞前夜和圣诞节期间全球数千次航班取消之后出现的。取消航班可能会打乱旅行计划，而此时许多人正乘飞机与家人共度圣诞假期。在美国，这一传统今年似乎有所反弹：根据交通安全管理局（Transportation Security Administration）的数据，上周每天大约有200万人通过安检，而平安夜和圣诞节的人数几乎是去年的两倍。</p>\n<p><img src=\"https://static.tigerbbs.com/b4003025308bf64f066cd7aed5a06db1\" tg-width=\"550\" tg-height=\"291\" referrerpolicy=\"no-referrer\"></p>\n<p><b>疫情下世界各国收紧新年庆典防疫政策 多地取消活动</b></p>\n<p>由于新冠omicron变种的传播，世界各地的大城市正在取消他们的新年庆祝活动，而其他城市正在推进他们的计划。</p>\n<p>纽约市标志性的新年庆祝活动将如期举行，但市长比尔·德布拉<a href=\"https://laohu8.com/S/SIAL\">西奥</a>表示，由于奥密克戎变异病毒的传播，参加派对的人将不得不接受全面接种，戴上口罩，并采取社交疏远措施，活动因此将“缩减规模”。</p>\n<p>这位美国最大城市的市长解释说：“纽约人在过去的一年里取得了巨大的进步——我们在疫苗接种方面处于领先地位，我们已经安全地重新开放，每天我们都在努力为我们所有人建设一个恢复期．．．．．．有很多值得庆祝的事情，这些额外的安全措施将在新年来临之际让接种疫苗的人群保持安全和健康。”</p>\n<p>全球其他城市采取了不同的做法，有的完全取消了庆祝活动。</p>\n<p><img src=\"https://static.tigerbbs.com/c2abf615da9d23bee2f444dbfcb67f75\" tg-width=\"550\" tg-height=\"366\" referrerpolicy=\"no-referrer\"></p>\n<p><b>福奇警告美国人不要对病毒掉以轻心 医院有可能被挤爆</b></p>\n<p>美国总统拜登的首席医学顾问福奇周日表示，尽管迹象表明omicron的症状可能不那么严重，但美国人仍应保持警惕，因为病患数量可能导致医院不堪重负。</p>\n<p>福奇在节目“This Week”上对记者Jonathan Karl说，“我们不希望看到大家掉以轻心，虽然omicron的病症不严重，但出现这么多新确诊病例可能抵消该因素”。</p>\n<p>来自苏格兰的初步数据显示，omicron“带来的住院风险比德尔塔低三分之二”，研究同时也表明，omicron导致二次感染新冠病毒的可能性是德尔塔的10倍左右。</p>\n<p>据报道，美国单日新增omicron感染病例已超过德尔塔病毒感染者，<a href=\"https://laohu8.com/S/AAL\">美国航空</a>企业在长周末假期取消了近1，900个航班，因为病例激增导致工作人员短缺。</p>\n<p><img src=\"https://static.tigerbbs.com/a5dc1c2269bd67acb592df752986ba66\" tg-width=\"550\" tg-height=\"343\" referrerpolicy=\"no-referrer\"></p>\n<p><b>英国智库：世界经济规模预计在明年超过100万亿美元</b></p>\n<p>根据一份预测，2022年世界经济规模势将首次超过100万亿美元，比先前预测的时间提早两年。</p>\n<p>总部位于英国伦敦的经济与商业研究中心（Centre for Economics and Business Research， CEBR）认为，全球国内生产总值（GDP）将受到疫情持续复苏的提振，不过如果通胀持续，决策者可能很难防止经济再度陷入衰退。</p>\n<p>“21世纪20年代的重要问题是全球经济体如何应对通胀，” CEBR副主席Douglas McWilliams表示。 “我们希望能用相对温和的调整来使得非暂时性因素得到控制。如果不这样，那么世界将需要为2023年或2024年的经济衰退做好准备。”</p>\n<p><img src=\"https://static.tigerbbs.com/4fd25fb23bbaab45631729cf6e09db84\" tg-width=\"500\" tg-height=\"333\" referrerpolicy=\"no-referrer\"></p>\n<p><b>土耳其颁布新措施救市 里拉短时间内大幅度反弹</b></p>\n<p>土耳其里拉本周走出一波大幅上涨行情，里拉对美元汇率由20日的18比1左右急速攀升至最高时的10比1左右，最终维持在11比1左右，涨幅逾40%，回到上月中下旬时的水平。</p>\n<p>近期，里拉汇率屡现剧烈波动行情。16日，里拉对美元汇率跌破15比1大关；17日，里拉对美元汇率跌破16和17两个整数关口；20日，里拉对美元汇率跌破18比1大关。本月以来，土耳其<a href=\"https://laohu8.com/S/CNBC\">中央银行</a>已经五次干预外汇市场。</p>\n<p>20日晚，土耳其总统埃尔多安宣布新救市措施，里拉汇率随即一转颓势，大幅上扬并逐渐企稳。救市措施包括一项新的金融替代方案，为本币储蓄因里拉贬值蒙受的损失提供补偿，以减少汇率波动对储户的影响。同时，政府将采取大幅提高个人养老金补贴等措施，以减轻民众生活成本压力。</p>\n<p><img src=\"https://static.tigerbbs.com/9e1d7eff89b4a5234ad828b7dca303d5\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\"></p>\n<p><b>万事达报告称假日销售飙升 电子商务获得巨大收益</b></p>\n<p>根据万事达卡（Mastercard）周日发布的一份报告，与2019年的假日期间相比，美国本季度的零售额增长了近11%。2019年是新冠大流行颠覆全球经济的前一年。</p>\n<p>这份名为Mastercard SpendingPulse的报告显示，与去年相比，在11月1日至12月24日的假日期间，零售销售额增长了8.5%。这些数据不包括汽车销售。</p>\n<p>与去年相比，实体店的销售额增长了8.1%，电子商务销售额增长了11%。与2019年相比，在新冠肺炎疫情导致网上订单激增之前，电子商务销售额增长了61%以上。</p>\n<p>根据万事达卡的报告，今年网上销售占零售总额的20.9%。2019年，在线销售仅占所有零售销售的14.6%，突显出疫情如何加速了向电子商务的转变。</p>\n<p>万事达卡高级顾问史蒂夫·萨多夫在一份声明中表示，许多美国人今年提前完成了圣诞购物。他说：“购物者急于在零售热潮到来之前确保自己的礼物，对供应链和劳动力供应问题的讨论让消费者成群结队地来到网上和商店（进行消费）。”</p>","source":"sina_us","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒头条：奥密克戎重挫航空旅行！周日数千个航班被取消</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒头条：奥密克戎重挫航空旅行！周日数千个航班被取消\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 05:46 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2021-12-27/doc-ikyakumx6577426.shtml><strong>市场资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、奥密克戎重挫航空旅行 周日全球数千个航班被取消\n\n\n2、疫情下世界各国收紧新年庆典防疫政策 多地取消活动\n\n\n3、福奇警告美国人不要对病毒掉以轻心 医院有可能被挤爆\n\n\n4、英国智库：世界经济规模预计在明年超过100万亿美元\n\n\n5、土耳其颁布新措施救市 里拉短时间内大幅度反弹\n\n\n6、万事达报告称假日销售飙升 电子商务获得巨大收益\n\n\n...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-12-27/doc-ikyakumx6577426.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/c2abf615da9d23bee2f444dbfcb67f75","relate_stocks":{"BK4566":"资本集团",".IXIC":"NASDAQ Composite","BK4527":"明星科技股","BK4213":"石油与天然气的勘探与生产","BK4559":"巴菲特持仓","BK4535":"淡马锡持仓","GDP":"古德里奇","BK4548":"巴美列捷福持仓",".SPX":"S&P 500 Index","BK4106":"数据处理与外包服务","BK4533":"AQR资本管理(全球第二大对冲基金)",".DJI":"道琼斯","MA":"万事达"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-12-27/doc-ikyakumx6577426.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194177763","content_text":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、奥密克戎重挫航空旅行 周日全球数千个航班被取消\n\n\n2、疫情下世界各国收紧新年庆典防疫政策 多地取消活动\n\n\n3、福奇警告美国人不要对病毒掉以轻心 医院有可能被挤爆\n\n\n4、英国智库：世界经济规模预计在明年超过100万亿美元\n\n\n5、土耳其颁布新措施救市 里拉短时间内大幅度反弹\n\n\n6、万事达报告称假日销售飙升 电子商务获得巨大收益\n\n\n奥密克戎重挫航空旅行 周日全球数千个航班被取消\n周日，美国数百个航班和全球数千个航班被取消，原因是在今年最繁忙的一个周末，奥密克戎变种病毒导致机组人员患病。\n据提供航空数据的FlightAware称，截至周日中午，至少有一站在美国的750多个航班被取消，而全球航班的取消数字则是其10倍。\n周日的惨淡记录是在圣诞前夜和圣诞节期间全球数千次航班取消之后出现的。取消航班可能会打乱旅行计划，而此时许多人正乘飞机与家人共度圣诞假期。在美国，这一传统今年似乎有所反弹：根据交通安全管理局（Transportation Security Administration）的数据，上周每天大约有200万人通过安检，而平安夜和圣诞节的人数几乎是去年的两倍。\n\n疫情下世界各国收紧新年庆典防疫政策 多地取消活动\n由于新冠omicron变种的传播，世界各地的大城市正在取消他们的新年庆祝活动，而其他城市正在推进他们的计划。\n纽约市标志性的新年庆祝活动将如期举行，但市长比尔·德布拉西奥表示，由于奥密克戎变异病毒的传播，参加派对的人将不得不接受全面接种，戴上口罩，并采取社交疏远措施，活动因此将“缩减规模”。\n这位美国最大城市的市长解释说：“纽约人在过去的一年里取得了巨大的进步——我们在疫苗接种方面处于领先地位，我们已经安全地重新开放，每天我们都在努力为我们所有人建设一个恢复期．．．．．．有很多值得庆祝的事情，这些额外的安全措施将在新年来临之际让接种疫苗的人群保持安全和健康。”\n全球其他城市采取了不同的做法，有的完全取消了庆祝活动。\n\n福奇警告美国人不要对病毒掉以轻心 医院有可能被挤爆\n美国总统拜登的首席医学顾问福奇周日表示，尽管迹象表明omicron的症状可能不那么严重，但美国人仍应保持警惕，因为病患数量可能导致医院不堪重负。\n福奇在节目“This Week”上对记者Jonathan Karl说，“我们不希望看到大家掉以轻心，虽然omicron的病症不严重，但出现这么多新确诊病例可能抵消该因素”。\n来自苏格兰的初步数据显示，omicron“带来的住院风险比德尔塔低三分之二”，研究同时也表明，omicron导致二次感染新冠病毒的可能性是德尔塔的10倍左右。\n据报道，美国单日新增omicron感染病例已超过德尔塔病毒感染者，美国航空企业在长周末假期取消了近1，900个航班，因为病例激增导致工作人员短缺。\n\n英国智库：世界经济规模预计在明年超过100万亿美元\n根据一份预测，2022年世界经济规模势将首次超过100万亿美元，比先前预测的时间提早两年。\n总部位于英国伦敦的经济与商业研究中心（Centre for Economics and Business Research， CEBR）认为，全球国内生产总值（GDP）将受到疫情持续复苏的提振，不过如果通胀持续，决策者可能很难防止经济再度陷入衰退。\n“21世纪20年代的重要问题是全球经济体如何应对通胀，” CEBR副主席Douglas McWilliams表示。 “我们希望能用相对温和的调整来使得非暂时性因素得到控制。如果不这样，那么世界将需要为2023年或2024年的经济衰退做好准备。”\n\n土耳其颁布新措施救市 里拉短时间内大幅度反弹\n土耳其里拉本周走出一波大幅上涨行情，里拉对美元汇率由20日的18比1左右急速攀升至最高时的10比1左右，最终维持在11比1左右，涨幅逾40%，回到上月中下旬时的水平。\n近期，里拉汇率屡现剧烈波动行情。16日，里拉对美元汇率跌破15比1大关；17日，里拉对美元汇率跌破16和17两个整数关口；20日，里拉对美元汇率跌破18比1大关。本月以来，土耳其中央银行已经五次干预外汇市场。\n20日晚，土耳其总统埃尔多安宣布新救市措施，里拉汇率随即一转颓势，大幅上扬并逐渐企稳。救市措施包括一项新的金融替代方案，为本币储蓄因里拉贬值蒙受的损失提供补偿，以减少汇率波动对储户的影响。同时，政府将采取大幅提高个人养老金补贴等措施，以减轻民众生活成本压力。\n\n万事达报告称假日销售飙升 电子商务获得巨大收益\n根据万事达卡（Mastercard）周日发布的一份报告，与2019年的假日期间相比，美国本季度的零售额增长了近11%。2019年是新冠大流行颠覆全球经济的前一年。\n这份名为Mastercard SpendingPulse的报告显示，与去年相比，在11月1日至12月24日的假日期间，零售销售额增长了8.5%。这些数据不包括汽车销售。\n与去年相比，实体店的销售额增长了8.1%，电子商务销售额增长了11%。与2019年相比，在新冠肺炎疫情导致网上订单激增之前，电子商务销售额增长了61%以上。\n根据万事达卡的报告，今年网上销售占零售总额的20.9%。2019年，在线销售仅占所有零售销售的14.6%，突显出疫情如何加速了向电子商务的转变。\n万事达卡高级顾问史蒂夫·萨多夫在一份声明中表示，许多美国人今年提前完成了圣诞购物。他说：“购物者急于在零售热潮到来之前确保自己的礼物，对供应链和劳动力供应问题的讨论让消费者成群结队地来到网上和商店（进行消费）。”","news_type":1,"symbols_score_info":{".DJI":0,"GDP":0,".IXIC":0,"MA":0,".SPX":0}},"isVote":1,"tweetType":1,"viewCount":3920,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698588679,"gmtCreate":1640449073531,"gmtModify":1640449073632,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698588679","repostId":"2193317305","repostType":4,"isVote":1,"tweetType":1,"viewCount":923,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698213202,"gmtCreate":1640403230263,"gmtModify":1640403230393,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698213202","repostId":"2193178191","repostType":4,"isVote":1,"tweetType":1,"viewCount":1002,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698213142,"gmtCreate":1640403169285,"gmtModify":1640403169411,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698213142","repostId":"1156159690","repostType":4,"isVote":1,"tweetType":1,"viewCount":840,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698213302,"gmtCreate":1640403153306,"gmtModify":1640403153391,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Informative!","listText":"Informative!","text":"Informative!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698213302","repostId":"2193917872","repostType":4,"isVote":1,"tweetType":1,"viewCount":887,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693004514,"gmtCreate":1639920163065,"gmtModify":1639920163203,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Ok great!","listText":"Ok great!","text":"Ok great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693004514","repostId":"2192903795","repostType":4,"isVote":1,"tweetType":1,"viewCount":1021,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693004175,"gmtCreate":1639920131883,"gmtModify":1639920132008,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693004175","repostId":"2192903248","repostType":4,"isVote":1,"tweetType":1,"viewCount":996,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699153731,"gmtCreate":1639757976925,"gmtModify":1639757987795,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Hope all goes well moving into 2022.","listText":"Hope all goes well moving into 2022.","text":"Hope all goes well moving into 2022.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699153731","isVote":1,"tweetType":1,"viewCount":850,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607601000,"gmtCreate":1639529579566,"gmtModify":1639529579637,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TAK\">$Takeda Pharmaceutical Co Ltd(TAK)$</a>Come on TAK... You possess good potential.. Up!","listText":"<a href=\"https://laohu8.com/S/TAK\">$Takeda Pharmaceutical Co Ltd(TAK)$</a>Come on TAK... You possess good potential.. Up!","text":"$Takeda Pharmaceutical Co Ltd(TAK)$Come on TAK... You possess good potential.. Up!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607601000","isVote":1,"tweetType":1,"viewCount":1081,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604750988,"gmtCreate":1639448597030,"gmtModify":1639448597030,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"Awesome","listText":"Awesome","text":"Awesome","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604750988","repostId":"2191890219","repostType":4,"isVote":1,"tweetType":1,"viewCount":1175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608143661,"gmtCreate":1638670894224,"gmtModify":1638670894224,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098943201642940","idStr":"4098943201642940"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>rise again please....","listText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>rise again please....","text":"$iSpecimen Inc.(ISPC)$rise again please....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608143661","isVote":1,"tweetType":1,"viewCount":2079,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":696522373,"gmtCreate":1640738199041,"gmtModify":1640738401450,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Slow and steady !","listText":"Slow and steady !","text":"Slow and steady !","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/696522373","repostId":"1113618075","repostType":4,"repost":{"id":"1113618075","kind":"news","pubTimestamp":1640736836,"share":"https://www.laohu8.com/m/news/1113618075?lang=zh_CN&edition=full","pubTime":"2021-12-29 08:13","market":"sg","language":"en","title":"Singapore Stock Market Called Rangebound For Wednesday<blockquote>新加坡股市周三区间震荡</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1113618075","media":"RTTNews","summary":"The Singapore stock market rebounded on Tuesday, one session after snapping the four-day winning str","content":"<p>The Singapore stock market rebounded on Tuesday, one session after snapping the four-day winning streak in which it had gathered almost 35 points or 1.2 percent. The Straits Times Index now sits just beneath the 3,130-point plateau and it's expected to remain in that neighborhood again on Wednesday.</p><p><blockquote>新加坡股市周二反弹，此前一个交易日结束了连续四天上涨近35点或1.2%。海峡时报指数目前略低于3,130点的高位，预计周三将再次保持在该附近。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is mixed, with support expected from oil companies and weakness likely from tech shares. The European and U.S. markets were mixed and the Asian bourses figure to follow suit.</p><p><blockquote>全球对亚洲市场的预测好坏参半，预计石油公司将提供支撑，科技股可能疲软。欧洲和美国市场涨跌互现，亚洲股市也将效仿。</blockquote></p><p> The STI finished modestly higher on Tuesday following gains from the financial shares, property stocks and industrial issues.</p><p><blockquote>继金融股、房地产股和工业股上涨后，海指周二小幅收高。</blockquote></p><p> For the day, the index collected 24.17 points or 0.78 percent to finish at 3,128.41 after trading between 3,108.93 and 3,128.92. Volume was 975.3 million shares worth 489.9 million Singapore dollars. There were 290 gainers and 175 decliners.</p><p><blockquote>当天，该指数在3,108.93至3,128.92之间交易后，上涨24.17点或0.78%，收于3,128.41点。成交量为9.753亿股，价值4.899亿新元。上涨股290股，下跌股175股。</blockquote></p><p> Among the actives, Ascendas REIT increased 0.68 percent, CapitaLand Integrated Commercial Trust soared 1.50 percent, City Developments advanced 0.89 percent, Comfort DelGro accelerated 1.45 percent, Dairy Farm International surged 3.57 percent, DBS Group rose 0.77 percent, Genting Singapore improved 0.65 percent, Keppel Corp perked 0.98 percent, Mapletree Logistics Trust strengthened 0.54 percent, Oversea-Chinese Banking Corporation added 0.88 percent, SATS jumped 1.30 percent, SembCorp Industries was up 0.50 percent, Singapore Airlines gathered 1.01 percent, Singapore Exchange gained 0.86 percent, Singapore Technologies Engineering climbed 1.08 percent, SingTel rallied 1.29 percent, Thai Beverage lost 0.75 percent, United Overseas Bank collected 0.64 percent, Wilmar International spiked 1.47 percent and Yangzijiang Shipbuilding, Mapletree Commercial Trust and Singapore Press Holdings were unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托上涨0.68%，凯德综合商业信托飙升1.50%，City Developments上涨0.89%，Comfort DelGro加速上涨1.45%，Dairy Farm International飙升3.57%，星展集团上涨0.77%，云顶新加坡上涨0.65%，吉宝企业上涨0.98%，丰树物流信托上涨0.54%，华侨银行上涨0.88%，胜科工业上涨0.50%，新加坡航空上涨1.01%，新加坡交易所上涨0.86%，新加坡科技工程上涨1.08%，新加坡电信上涨1.29%，泰国饮料下跌0.75%，丰益国际上涨1.47%，扬子江造船、丰树商业信托和新加坡报业控股持平。</blockquote></p><p> The lead from Wall Street is mixed as the Dow opened higher on Thursday and stayed that way, the S&amp;P 500 opened higher but gradually fell into the red and the NASDAQ simply spent most of the day in negative territory.</p><p><blockquote>华尔街的领先优势好坏参半，道琼斯指数周四高开并保持这种状态，标普500高开但逐渐陷入亏损，纳斯达克则全天大部分时间都处于负值区域。</blockquote></p><p> The Dow gained 95.83 points or 0.26 percent to finish at 36,398.21, while the NASDAQ sank 89.54 points or 0.56 percent to close at 15,781.72 and the S&amp;P 500 eased 4.84 points or 0.10 percent to end at 4,786.35.</p><p><blockquote>道琼斯指数上涨95.83点或0.26%，收于36,398.21点；纳斯达克下跌89.54点或0.56%，收于15,781.72点；标普500下跌4.84点或0.10%，收于4,786.35点。</blockquote></p><p> The lackluster performance came as traders were reluctant to continue making significant moves following the recent strength in the markets. But they largely refrained from cashing in on recent gains amid easing concerns about the impact of the Omicron variant of the&nbsp;coronavirus.</p><p><blockquote>由于近期市场走强后，交易员不愿继续采取重大举措，因此表现低迷。但由于对冠状病毒奥密克戎变种影响的担忧有所缓解，他们基本上没有兑现近期的涨幅。</blockquote></p><p> Helping offset worries about the pandemic, the Centers for Disease Control and Prevention has shortened the recommended isolation time to for asymptomatic people with Covid-19 to 5 days from 10 days.</p><p><blockquote>为了帮助抵消对疫情的担忧，疾病控制和预防中心将无症状新冠肺炎患者的建议隔离时间从10天缩短到5天。</blockquote></p><p> Crude oil futures rose Tuesday, extending gains to a fifth straight session on hopes the Omicron variant of the coronavirus is unlikely to impact global economic recovery. West Texas Intermediate Crude oil futures for February added $0.41 or 0.5 percent at $75.98 a barrel.</p><p><blockquote>原油期货周二上涨，连续第五个交易日上涨，因人们希望冠状病毒的奥密克戎变种不太可能影响全球经济复苏。西德克萨斯中质原油2月期货价格上涨0.41美元，或0.5%，报每桶75.98美元。</blockquote></p><p> Closer to home, Singapore will release November numbers for import, export and producer prices later today. In October, import prices rose 20.0 percent on year, while export prices jumped an annual 20.7 percent and producer prices spiked 25.4 percent.</p><p><blockquote>言归正传，新加坡将于今天晚些时候公布11月份的进口、出口和生产者价格数据。10月份，进口价格同比上涨20.0%，出口价格同比上涨20.7%，生产者价格飙升25.4%。</blockquote></p><p></p>","source":"lsy1626938412129","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore Stock Market Called Rangebound For Wednesday<blockquote>新加坡股市周三区间震荡</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore Stock Market Called Rangebound For Wednesday<blockquote>新加坡股市周三区间震荡</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">RTTNews</strong><span class=\"h-time small\">2021-12-29 08:13</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The Singapore stock market rebounded on Tuesday, one session after snapping the four-day winning streak in which it had gathered almost 35 points or 1.2 percent. The Straits Times Index now sits just beneath the 3,130-point plateau and it's expected to remain in that neighborhood again on Wednesday.</p><p><blockquote>新加坡股市周二反弹，此前一个交易日结束了连续四天上涨近35点或1.2%。海峡时报指数目前略低于3,130点的高位，预计周三将再次保持在该附近。</blockquote></p><p> The global forecast for the Asian&nbsp;markets&nbsp;is mixed, with support expected from oil companies and weakness likely from tech shares. The European and U.S. markets were mixed and the Asian bourses figure to follow suit.</p><p><blockquote>全球对亚洲市场的预测好坏参半，预计石油公司将提供支撑，科技股可能疲软。欧洲和美国市场涨跌互现，亚洲股市也将效仿。</blockquote></p><p> The STI finished modestly higher on Tuesday following gains from the financial shares, property stocks and industrial issues.</p><p><blockquote>继金融股、房地产股和工业股上涨后，海指周二小幅收高。</blockquote></p><p> For the day, the index collected 24.17 points or 0.78 percent to finish at 3,128.41 after trading between 3,108.93 and 3,128.92. Volume was 975.3 million shares worth 489.9 million Singapore dollars. There were 290 gainers and 175 decliners.</p><p><blockquote>当天，该指数在3,108.93至3,128.92之间交易后，上涨24.17点或0.78%，收于3,128.41点。成交量为9.753亿股，价值4.899亿新元。上涨股290股，下跌股175股。</blockquote></p><p> Among the actives, Ascendas REIT increased 0.68 percent, CapitaLand Integrated Commercial Trust soared 1.50 percent, City Developments advanced 0.89 percent, Comfort DelGro accelerated 1.45 percent, Dairy Farm International surged 3.57 percent, DBS Group rose 0.77 percent, Genting Singapore improved 0.65 percent, Keppel Corp perked 0.98 percent, Mapletree Logistics Trust strengthened 0.54 percent, Oversea-Chinese Banking Corporation added 0.88 percent, SATS jumped 1.30 percent, SembCorp Industries was up 0.50 percent, Singapore Airlines gathered 1.01 percent, Singapore Exchange gained 0.86 percent, Singapore Technologies Engineering climbed 1.08 percent, SingTel rallied 1.29 percent, Thai Beverage lost 0.75 percent, United Overseas Bank collected 0.64 percent, Wilmar International spiked 1.47 percent and Yangzijiang Shipbuilding, Mapletree Commercial Trust and Singapore Press Holdings were unchanged.</p><p><blockquote>活跃股中，腾飞房地产投资信托上涨0.68%，凯德综合商业信托飙升1.50%，City Developments上涨0.89%，Comfort DelGro加速上涨1.45%，Dairy Farm International飙升3.57%，星展集团上涨0.77%，云顶新加坡上涨0.65%，吉宝企业上涨0.98%，丰树物流信托上涨0.54%，华侨银行上涨0.88%，胜科工业上涨0.50%，新加坡航空上涨1.01%，新加坡交易所上涨0.86%，新加坡科技工程上涨1.08%，新加坡电信上涨1.29%，泰国饮料下跌0.75%，丰益国际上涨1.47%，扬子江造船、丰树商业信托和新加坡报业控股持平。</blockquote></p><p> The lead from Wall Street is mixed as the Dow opened higher on Thursday and stayed that way, the S&amp;P 500 opened higher but gradually fell into the red and the NASDAQ simply spent most of the day in negative territory.</p><p><blockquote>华尔街的领先优势好坏参半，道琼斯指数周四高开并保持这种状态，标普500高开但逐渐陷入亏损，纳斯达克则全天大部分时间都处于负值区域。</blockquote></p><p> The Dow gained 95.83 points or 0.26 percent to finish at 36,398.21, while the NASDAQ sank 89.54 points or 0.56 percent to close at 15,781.72 and the S&amp;P 500 eased 4.84 points or 0.10 percent to end at 4,786.35.</p><p><blockquote>道琼斯指数上涨95.83点或0.26%，收于36,398.21点；纳斯达克下跌89.54点或0.56%，收于15,781.72点；标普500下跌4.84点或0.10%，收于4,786.35点。</blockquote></p><p> The lackluster performance came as traders were reluctant to continue making significant moves following the recent strength in the markets. But they largely refrained from cashing in on recent gains amid easing concerns about the impact of the Omicron variant of the&nbsp;coronavirus.</p><p><blockquote>由于近期市场走强后，交易员不愿继续采取重大举措，因此表现低迷。但由于对冠状病毒奥密克戎变种影响的担忧有所缓解，他们基本上没有兑现近期的涨幅。</blockquote></p><p> Helping offset worries about the pandemic, the Centers for Disease Control and Prevention has shortened the recommended isolation time to for asymptomatic people with Covid-19 to 5 days from 10 days.</p><p><blockquote>为了帮助抵消对疫情的担忧，疾病控制和预防中心将无症状新冠肺炎患者的建议隔离时间从10天缩短到5天。</blockquote></p><p> Crude oil futures rose Tuesday, extending gains to a fifth straight session on hopes the Omicron variant of the coronavirus is unlikely to impact global economic recovery. West Texas Intermediate Crude oil futures for February added $0.41 or 0.5 percent at $75.98 a barrel.</p><p><blockquote>原油期货周二上涨，连续第五个交易日上涨，因人们希望冠状病毒的奥密克戎变种不太可能影响全球经济复苏。西德克萨斯中质原油2月期货价格上涨0.41美元，或0.5%，报每桶75.98美元。</blockquote></p><p> Closer to home, Singapore will release November numbers for import, export and producer prices later today. In October, import prices rose 20.0 percent on year, while export prices jumped an annual 20.7 percent and producer prices spiked 25.4 percent.</p><p><blockquote>言归正传，新加坡将于今天晚些时候公布11月份的进口、出口和生产者价格数据。10月份，进口价格同比上涨20.0%，出口价格同比上涨20.7%，生产者价格飙升25.4%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.rttnews.com/3251796/singapore-stock-market-called-rangebound-for-wednesday.aspx?type=acom\">RTTNews</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.rttnews.com/3251796/singapore-stock-market-called-rangebound-for-wednesday.aspx?type=acom","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113618075","content_text":"The Singapore stock market rebounded on Tuesday, one session after snapping the four-day winning streak in which it had gathered almost 35 points or 1.2 percent. The Straits Times Index now sits just beneath the 3,130-point plateau and it's expected to remain in that neighborhood again on Wednesday.\nThe global forecast for the Asian markets is mixed, with support expected from oil companies and weakness likely from tech shares. The European and U.S. markets were mixed and the Asian bourses figure to follow suit.\nThe STI finished modestly higher on Tuesday following gains from the financial shares, property stocks and industrial issues.\nFor the day, the index collected 24.17 points or 0.78 percent to finish at 3,128.41 after trading between 3,108.93 and 3,128.92. Volume was 975.3 million shares worth 489.9 million Singapore dollars. There were 290 gainers and 175 decliners.\nAmong the actives, Ascendas REIT increased 0.68 percent, CapitaLand Integrated Commercial Trust soared 1.50 percent, City Developments advanced 0.89 percent, Comfort DelGro accelerated 1.45 percent, Dairy Farm International surged 3.57 percent, DBS Group rose 0.77 percent, Genting Singapore improved 0.65 percent, Keppel Corp perked 0.98 percent, Mapletree Logistics Trust strengthened 0.54 percent, Oversea-Chinese Banking Corporation added 0.88 percent, SATS jumped 1.30 percent, SembCorp Industries was up 0.50 percent, Singapore Airlines gathered 1.01 percent, Singapore Exchange gained 0.86 percent, Singapore Technologies Engineering climbed 1.08 percent, SingTel rallied 1.29 percent, Thai Beverage lost 0.75 percent, United Overseas Bank collected 0.64 percent, Wilmar International spiked 1.47 percent and Yangzijiang Shipbuilding, Mapletree Commercial Trust and Singapore Press Holdings were unchanged.\nThe lead from Wall Street is mixed as the Dow opened higher on Thursday and stayed that way, the S&P 500 opened higher but gradually fell into the red and the NASDAQ simply spent most of the day in negative territory.\nThe Dow gained 95.83 points or 0.26 percent to finish at 36,398.21, while the NASDAQ sank 89.54 points or 0.56 percent to close at 15,781.72 and the S&P 500 eased 4.84 points or 0.10 percent to end at 4,786.35.\nThe lackluster performance came as traders were reluctant to continue making significant moves following the recent strength in the markets. But they largely refrained from cashing in on recent gains amid easing concerns about the impact of the Omicron variant of the coronavirus.\nHelping offset worries about the pandemic, the Centers for Disease Control and Prevention has shortened the recommended isolation time to for asymptomatic people with Covid-19 to 5 days from 10 days.\nCrude oil futures rose Tuesday, extending gains to a fifth straight session on hopes the Omicron variant of the coronavirus is unlikely to impact global economic recovery. West Texas Intermediate Crude oil futures for February added $0.41 or 0.5 percent at $75.98 a barrel.\nCloser to home, Singapore will release November numbers for import, export and producer prices later today. In October, import prices rose 20.0 percent on year, while export prices jumped an annual 20.7 percent and producer prices spiked 25.4 percent.","news_type":1,"symbols_score_info":{"STI.SI":0.9}},"isVote":1,"tweetType":1,"viewCount":2929,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608143661,"gmtCreate":1638670894224,"gmtModify":1638670894224,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>rise again please....","listText":"<a href=\"https://laohu8.com/S/ISPC\">$iSpecimen Inc.(ISPC)$</a>rise again please....","text":"$iSpecimen Inc.(ISPC)$rise again please....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608143661","isVote":1,"tweetType":1,"viewCount":2079,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698213302,"gmtCreate":1640403153306,"gmtModify":1640403153391,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Informative!","listText":"Informative!","text":"Informative!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698213302","repostId":"2193917872","repostType":4,"isVote":1,"tweetType":1,"viewCount":887,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693004514,"gmtCreate":1639920163065,"gmtModify":1639920163203,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Ok great!","listText":"Ok great!","text":"Ok great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693004514","repostId":"2192903795","repostType":4,"isVote":1,"tweetType":1,"viewCount":1021,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698588679,"gmtCreate":1640449073531,"gmtModify":1640449073632,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698588679","repostId":"2193317305","repostType":4,"isVote":1,"tweetType":1,"viewCount":923,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698213202,"gmtCreate":1640403230263,"gmtModify":1640403230393,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698213202","repostId":"2193178191","repostType":4,"isVote":1,"tweetType":1,"viewCount":1002,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604750988,"gmtCreate":1639448597030,"gmtModify":1639448597030,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Awesome","listText":"Awesome","text":"Awesome","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604750988","repostId":"2191890219","repostType":4,"isVote":1,"tweetType":1,"viewCount":1175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692241460,"gmtCreate":1641007146854,"gmtModify":1641007273977,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Yes of course!","listText":"Yes of course!","text":"Yes of course!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/692241460","repostId":"2195448557","repostType":4,"isVote":1,"tweetType":1,"viewCount":2966,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871530787,"gmtCreate":1637079786068,"gmtModify":1637080527975,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Come Apple.. Soar!","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Come Apple.. Soar!","text":"$Apple(AAPL)$Come Apple.. Soar!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871530787","isVote":1,"tweetType":1,"viewCount":656,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698213142,"gmtCreate":1640403169285,"gmtModify":1640403169411,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698213142","repostId":"1156159690","repostType":4,"isVote":1,"tweetType":1,"viewCount":840,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696522867,"gmtCreate":1640738222192,"gmtModify":1640738401567,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"[smile]&nbsp;","listText":"[smile]&nbsp;","text":"[smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696522867","repostId":"1163970983","repostType":4,"repost":{"id":"1163970983","kind":"news","pubTimestamp":1640735883,"share":"https://www.laohu8.com/m/news/1163970983?lang=zh_CN&edition=full","pubTime":"2021-12-29 07:58","market":"us","language":"en","title":"ProShares Plans New Metaverse ETF as Demand for Funds Surges<blockquote>随着资金需求激增，ProShares计划推出新的元宇宙ETF</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1163970983","media":"Bloomberg","summary":"(Bloomberg) -- ProShares is planning to launch an exchange-traded fund focused on the metaverse, acc","content":"<p>(Bloomberg) -- ProShares is planning to launch an exchange-traded fund focused on the metaverse, according to a Tuesday filing with the U.S. Securities and Exchange Commission.</p><p><blockquote>（彭博社）——根据周二提交给美国证券交易委员会的文件，ProShares正计划推出一只专注于元宇宙的交易所交易基金。</blockquote></p><p> If approved, the ProShares Metaverse Theme ETF will track the performance of the Solactive Metaverse Theme Index.</p><p><blockquote>如果获得批准，ProShares元宇宙主题ETF将跟踪Solactive元宇宙主题指数的表现。</blockquote></p><p> The index consists of companies that provide or use technologies that offer products and services around the metaverse, like data processing and metaverse devices. <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc., <a href=\"https://laohu8.com/S/CASH\">Meta</a> Platforms Inc., and Nvidia Corp. are the index’s top weightings.</p><p><blockquote>该指数由提供或使用围绕元宇宙提供产品和服务的技术的公司组成，例如数据处理和元宇宙设备。<a href=\"https://laohu8.com/S/AAPL\">苹果</a>公司，<a href=\"https://laohu8.com/S/CASH\">元</a>Platforms Inc.和Nvidia Corp.是该指数权重最高的股票。</blockquote></p><p> ProShares is the latest firm seeking to capitalize on the emerging metaverse trend. Global metaverse ETF assets have surged to $2.2 billion as of Dec. 28, with most ETFs only launched in the last quarter. The Roundhill <a href=\"https://laohu8.com/S/BLL\">Ball</a> Metaverse (ticker META) has swelled to $916 million assets under management since its June 30 launch. In November, Canada saw two metaverse ETFs launched in <a href=\"https://laohu8.com/S/AONE.U\">one</a> day.</p><p><blockquote>ProShares是最新一家寻求利用新兴元宇宙趋势的公司。截至12月28日，全球元宇宙ETF资产已飙升至22亿美元，其中大多数ETF是上个季度才推出的。圆山<a href=\"https://laohu8.com/S/BLL\">球</a>自6月30日推出以来，元宇宙（股票代码META）管理的资产已增至9.16亿美元。11月，加拿大推出了两只元宇宙ETF<a href=\"https://laohu8.com/S/AONE.U\">一</a>天。</blockquote></p><p> “I don’t know if the metaverse theme has legs, but investors believe in it. Given the success of the ETF META, we are likely to see more products come to market that offer a unique twist on this long-term theme,” said Todd Rosenbluth, director of mutual fund and ETF research at CFRA.</p><p><blockquote>“我不知道元宇宙主题是否有立足点，但投资者相信它。鉴于ETF META的成功，我们可能会看到更多产品上市，为这一长期主题提供独特的转折，”CFRA共同基金和ETF研究总监Todd Rosenbluth表示。</blockquote></p><p> The Metaverse Theme ETF caps a monumental year for ProShares, in which it became the first firm to win approval from the U.S. SEC to launch a Bitcoin futures ETF. The fund debuted as the second-most heavily traded ETF on record.</p><p><blockquote>Metaverse主题ETF为ProShares具有里程碑意义的一年画上了句号，它成为第一家获得美国SEC批准推出比特币期货ETF的公司。该基金首次亮相时是有记录以来交易量第二大的ETF。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ProShares Plans New Metaverse ETF as Demand for Funds Surges<blockquote>随着资金需求激增，ProShares计划推出新的元宇宙ETF</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProShares Plans New Metaverse ETF as Demand for Funds Surges<blockquote>随着资金需求激增，ProShares计划推出新的元宇宙ETF</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-12-29 07:58</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- ProShares is planning to launch an exchange-traded fund focused on the metaverse, according to a Tuesday filing with the U.S. Securities and Exchange Commission.</p><p><blockquote>（彭博社）——根据周二提交给美国证券交易委员会的文件，ProShares正计划推出一只专注于元宇宙的交易所交易基金。</blockquote></p><p> If approved, the ProShares Metaverse Theme ETF will track the performance of the Solactive Metaverse Theme Index.</p><p><blockquote>如果获得批准，ProShares元宇宙主题ETF将跟踪Solactive元宇宙主题指数的表现。</blockquote></p><p> The index consists of companies that provide or use technologies that offer products and services around the metaverse, like data processing and metaverse devices. <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc., <a href=\"https://laohu8.com/S/CASH\">Meta</a> Platforms Inc., and Nvidia Corp. are the index’s top weightings.</p><p><blockquote>该指数由提供或使用围绕元宇宙提供产品和服务的技术的公司组成，例如数据处理和元宇宙设备。<a href=\"https://laohu8.com/S/AAPL\">苹果</a>公司，<a href=\"https://laohu8.com/S/CASH\">元</a>Platforms Inc.和Nvidia Corp.是该指数权重最高的股票。</blockquote></p><p> ProShares is the latest firm seeking to capitalize on the emerging metaverse trend. Global metaverse ETF assets have surged to $2.2 billion as of Dec. 28, with most ETFs only launched in the last quarter. The Roundhill <a href=\"https://laohu8.com/S/BLL\">Ball</a> Metaverse (ticker META) has swelled to $916 million assets under management since its June 30 launch. In November, Canada saw two metaverse ETFs launched in <a href=\"https://laohu8.com/S/AONE.U\">one</a> day.</p><p><blockquote>ProShares是最新一家寻求利用新兴元宇宙趋势的公司。截至12月28日，全球元宇宙ETF资产已飙升至22亿美元，其中大多数ETF是上个季度才推出的。圆山<a href=\"https://laohu8.com/S/BLL\">球</a>自6月30日推出以来，元宇宙（股票代码META）管理的资产已增至9.16亿美元。11月，加拿大推出了两只元宇宙ETF<a href=\"https://laohu8.com/S/AONE.U\">一</a>天。</blockquote></p><p> “I don’t know if the metaverse theme has legs, but investors believe in it. Given the success of the ETF META, we are likely to see more products come to market that offer a unique twist on this long-term theme,” said Todd Rosenbluth, director of mutual fund and ETF research at CFRA.</p><p><blockquote>“我不知道元宇宙主题是否有立足点，但投资者相信它。鉴于ETF META的成功，我们可能会看到更多产品上市，为这一长期主题提供独特的转折，”CFRA共同基金和ETF研究总监Todd Rosenbluth表示。</blockquote></p><p> The Metaverse Theme ETF caps a monumental year for ProShares, in which it became the first firm to win approval from the U.S. SEC to launch a Bitcoin futures ETF. The fund debuted as the second-most heavily traded ETF on record.</p><p><blockquote>Metaverse主题ETF为ProShares具有里程碑意义的一年画上了句号，它成为第一家获得美国SEC批准推出比特币期货ETF的公司。该基金首次亮相时是有记录以来交易量第二大的ETF。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/metaverse-etf-appetite-strong-proshares-215659170.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FB":"ProShares S&P 500 Dynamic Buffer ETF","NVDA":"英伟达","AAPL":"苹果","NGD":"New Gold"},"source_url":"https://finance.yahoo.com/news/metaverse-etf-appetite-strong-proshares-215659170.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163970983","content_text":"(Bloomberg) -- ProShares is planning to launch an exchange-traded fund focused on the metaverse, according to a Tuesday filing with the U.S. Securities and Exchange Commission.\nIf approved, the ProShares Metaverse Theme ETF will track the performance of the Solactive Metaverse Theme Index.\nThe index consists of companies that provide or use technologies that offer products and services around the metaverse, like data processing and metaverse devices. Apple Inc., Meta Platforms Inc., and Nvidia Corp. are the index’s top weightings.\nProShares is the latest firm seeking to capitalize on the emerging metaverse trend. Global metaverse ETF assets have surged to $2.2 billion as of Dec. 28, with most ETFs only launched in the last quarter. The Roundhill Ball Metaverse (ticker META) has swelled to $916 million assets under management since its June 30 launch. In November, Canada saw two metaverse ETFs launched in one day.\n“I don’t know if the metaverse theme has legs, but investors believe in it. Given the success of the ETF META, we are likely to see more products come to market that offer a unique twist on this long-term theme,” said Todd Rosenbluth, director of mutual fund and ETF research at CFRA.\nThe Metaverse Theme ETF caps a monumental year for ProShares, in which it became the first firm to win approval from the U.S. SEC to launch a Bitcoin futures ETF. The fund debuted as the second-most heavily traded ETF on record.","news_type":1,"symbols_score_info":{"AAPL":0.9,"NGD":0.9,"NVDA":0.9,"FB":0.9}},"isVote":1,"tweetType":1,"viewCount":3723,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600171934,"gmtCreate":1638107983241,"gmtModify":1638107983241,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Growing strong!","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Growing strong!","text":"$Apple(AAPL)$Growing strong!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/600171934","isVote":1,"tweetType":1,"viewCount":594,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872958727,"gmtCreate":1637402961751,"gmtModify":1637403021792,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872958727","repostId":"2184842262","repostType":4,"isVote":1,"tweetType":1,"viewCount":242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":695745165,"gmtCreate":1641629120965,"gmtModify":1641629121332,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/695745165","repostId":"1134509683","repostType":4,"repost":{"id":"1134509683","kind":"news","pubTimestamp":1641612579,"share":"https://www.laohu8.com/m/news/1134509683?lang=zh_CN&edition=full","pubTime":"2022-01-08 11:29","market":"us","language":"en","title":"3 COVID Stocks That Will Make Billions in 2022<blockquote>2022年将赚取数十亿美元的3只COVID股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1134509683","media":"Motley Fool","summary":"These three COVID-19 stocks could rake in a tremendous amount of cash this year.","content":"<p><html><head></head><body>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><blockquote><html><head></head><body>这是新的一年，新冠肺炎仍然和我们在一起。去年，我们看到医疗保健领域多种新冠疫苗和治疗方法获得了紧急使用授权。制药公司将在2022年赚取数十亿美元。以下是三只应该蓬勃发展的股票。</body></html></blockquote></p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p><blockquote><b>辉瑞</b>（纽约证券交易所股票代码：PFE）是一家价值3100亿美元的大型公司，预计其新冠疫苗和抗病毒药物的销售额将不会是10亿或100亿美元，而是超过500亿美元。斗志昂扬<b>Novavax</b>（纳斯达克：NVAX）终于在全球范围内推出了新冠疫苗。它将获得多少亿？我们有一个黑马候选人<b>维尔生物技术</b>（纳斯达克：维尔）。对于这家小型生物技术公司来说，它的一种药物很容易成为价值10亿美元的重磅炸弹。</blockquote></p><p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p><b>A safe harbor in stormy weather</b></p><p><blockquote><b>暴风雨天气中的避风港</b></blockquote></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p><blockquote><b>乔治·巴德威尔（辉瑞）：</b>辉瑞是新冠肺炎制药产品无可争议的冠军。仅在2022年，华尔街预计这家制药巨头的新型冠状病毒疫苗Comirnaty和口服抗病毒药物Paxlovid的销售额就将达到550亿美元。</blockquote></p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p><blockquote>更重要的是，分析师开始接受Paxlovid可能在当前十年内成为该公司可持续收入来源的想法。当该药物上个月首次被美国食品和药物管理局根据紧急使用授权途径允许上市时，华尔街认为从商业角度来看，Paxlovid可能会在一年左右的时间内达到顶峰，然后随着疫情从视野中消失，销售额急剧下降。</blockquote></p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p><blockquote>但距离该药物首次获得批准还不到三周，令人痛苦的是，很明显，Paxlovid可能需要作为未来几年COVID-19最坏结果的故障保险。毕竟，高传染性的奥密克戎变种肯定不会是该病毒的最后一次重大迭代。</blockquote></p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p><blockquote>这一切意味着，辉瑞应该是少数几家在新冠肺炎拥有可观、长期收入来源的大型制药商之一。反过来，在可预见的未来，辉瑞应该有充足的自由现金流来满足其慷慨的股东奖励计划以及雄心勃勃的业务发展计划。</blockquote></p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><blockquote>因此，如果您正在寻找一只能够抵御极高通胀和利率上升双重阻力的股票，辉瑞可能值得一试。</blockquote></p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><blockquote><b>Novavax的收入预测：20亿至80亿美元</b></blockquote></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p><blockquote><b>泰勒·卡迈克尔（Novavax）：</b>Novavax今年正处于伟大的边缘。该公司的股价跌至每股125美元。这就是它在2021年开始的地方，所以去年该股几乎遭受了洗盘。</blockquote></p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p><blockquote>早在2月份，当Novavax报告其新冠疫苗的积极3期数据时，股价就飙升至300美元以上。但后来这家小型生物技术公司遇到了制造问题。虽然许多人说它的疫苗是同类产品中最好的，但扩大约20亿剂疫苗的合同生产说起来容易做起来难。这些现实导致该股较高点下跌约60%。</blockquote></p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p><blockquote>尽管如此，Novavax的收入已经达到了10亿美元大关，因此由于所有的预订，其疫苗甚至在获得批准之前就已经一鸣惊人。现在，全球各地的授权纷至沓来，Novavax很有可能在2022年运送大量疫苗。该公司已经实现了每月1亿剂的生产能力，即一年12亿剂。在第三季度收益看涨期权上，管理层预测到第四季度末将达到每月1.5亿剂（或每年18亿剂）的生产能力。该公司预计将继续扩大规模，并预测2022年将分发20亿剂疫苗。</blockquote></p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p><blockquote>20亿剂疫苗，价格为16美元（曲速行动支付了16亿美元预购了1亿剂疫苗），我们粗略计算出收入为320亿美元。当然，Novavax将以较低的速度向发展中国家分发大量疫苗。尽管该公司对其价格保持沉默，但丹麦早在8月份就表示，根据欧盟(EU)协议，它为每剂疫苗支付了近21美元。欧盟已经订购了2亿剂，因此仅在欧洲的销售额就超过40亿美元。</blockquote></p><p></p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><blockquote>分析师非常保守，对Novavax 2022年的预测在20亿至80亿美元之间。（该公司的市值为90亿美元。）虽然一路上可能会出现一些问题，但Novavax肯定会在2022年从其COVID-19疫苗中赚取数十亿美元。如果该公司确实像其所说的那样交付20亿剂疫苗，该股可能会有大幅上涨空间。</blockquote></p><p><b>The antibody market all to itself</b></p><p><blockquote><b>抗体市场全靠自己</b></blockquote></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p><blockquote><b>Patrick Bafuma（Vir Biotechnology）：</b>奥密克戎变种目前猖獗，这一次，我们缺少一些治疗方法。以前青睐的单克隆抗体治疗来自<b>礼来公司</b>（bamlanivimab加etesevimab）以及来自<b>罗氏</b>和<b>再生</b>被认为对当前变体的活性显著降低。这样就只剩下一种对奥密克戎有效的输液了--<b>葛兰素史克</b>以及Vir Biotechnology的sotrovimab。这种单克隆抗体先前证明，在轻度至中度新冠肺炎和进展为重度疾病的高风险成人中，住院和死亡风险降低了79%。它是目前唯一一个对抗奥密克戎变种的人。</blockquote></p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p><blockquote>作为唯一的单克隆抗体将有其特权。2021年前9个月，REGEN-COV带来了35亿美元的产品净销售额，而礼来公司的抗体组合带来了11.7亿美元。美国政府已经签订了价值约10亿美元的sotrovimab合同。随着医院挤满了病人，任何有助于缓解系统压力的东西都可能受到高度追捧。</blockquote></p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p><p><blockquote>虽然辉瑞的Paxlovid将极大地有利于减轻医疗保健系统的COVID-19负担，但这种口服药物具有显着且复杂的药物相互作用潜力。事实上，它的相互作用列表读起来就像是常用处方药的名人录。这包括流行的血液稀释剂，如波立维和Xarelto，常见的止痛药，如曲马多和羟考酮，抗焦虑药，如Klonopin和Xanax，以及抗胆固醇他汀类药物。随着美国国立卫生研究院发表声明，表达了对Paxlovid可能的药物相互作用的担忧，这为sotrovimab继续广泛使用留下了充足的空间。根据与GSK的协议，Vir获得了sotrovimab销售额的72.5%，这家价值44亿美元的生物技术公司目前看起来很划算。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 COVID Stocks That Will Make Billions in 2022<blockquote>2022年将赚取数十亿美元的3只COVID股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 COVID Stocks That Will Make Billions in 2022<blockquote>2022年将赚取数十亿美元的3只COVID股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2022-01-08 11:29</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>It&#39;s a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.</p><p><blockquote><html><head></head><body>这是新的一年，新冠肺炎仍然和我们在一起。去年，我们看到医疗保健领域多种新冠疫苗和治疗方法获得了紧急使用授权。制药公司将在2022年赚取数十亿美元。以下是三只应该蓬勃发展的股票。</body></html></blockquote></p><p><b>Pfizer</b>(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy <b>Novavax</b>(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in <b>Vir Biotechnology</b>(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.</p><p><blockquote><b>辉瑞</b>（纽约证券交易所股票代码：PFE）是一家价值3100亿美元的大型公司，预计其新冠疫苗和抗病毒药物的销售额将不会是10亿或100亿美元，而是超过500亿美元。斗志昂扬<b>Novavax</b>（纳斯达克：NVAX）终于在全球范围内推出了新冠疫苗。它将获得多少亿？我们有一个黑马候选人<b>维尔生物技术</b>（纳斯达克：维尔）。对于这家小型生物技术公司来说，它的一种药物很容易成为价值10亿美元的重磅炸弹。</blockquote></p><p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/488a166201699c1f3d6536aa3e640ecf\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源：盖蒂图片社。</span></p></blockquote></p><p><b>A safe harbor in stormy weather</b></p><p><blockquote><b>暴风雨天气中的避风港</b></blockquote></p><p><b>George Budwell(Pfizer):</b>Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.</p><p><blockquote><b>乔治·巴德威尔（辉瑞）：</b>辉瑞是新冠肺炎制药产品无可争议的冠军。仅在2022年，华尔街预计这家制药巨头的新型冠状病毒疫苗Comirnaty和口服抗病毒药物Paxlovid的销售额就将达到550亿美元。</blockquote></p><p>What&#39;s more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.</p><p><blockquote>更重要的是，分析师开始接受Paxlovid可能在当前十年内成为该公司可持续收入来源的想法。当该药物上个月首次被美国食品和药物管理局根据紧急使用授权途径允许上市时，华尔街认为从商业角度来看，Paxlovid可能会在一年左右的时间内达到顶峰，然后随着疫情从视野中消失，销售额急剧下降。</blockquote></p><p>But less than three weeks out from the drug&#39;s initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.</p><p><blockquote>但距离该药物首次获得批准还不到三周，令人痛苦的是，很明显，Paxlovid可能需要作为未来几年COVID-19最坏结果的故障保险。毕竟，高传染性的奥密克戎变种肯定不会是该病毒的最后一次重大迭代。</blockquote></p><p>What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.</p><p><blockquote>这一切意味着，辉瑞应该是少数几家在新冠肺炎拥有可观、长期收入来源的大型制药商之一。反过来，在可预见的未来，辉瑞应该有充足的自由现金流来满足其慷慨的股东奖励计划以及雄心勃勃的业务发展计划。</blockquote></p><p>So, if you&#39;re looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.</p><p><blockquote>因此，如果您正在寻找一只能够抵御极高通胀和利率上升双重阻力的股票，辉瑞可能值得一试。</blockquote></p><p><b>Revenue forecasts for Novavax:  $2 billion to $8 billion</b></p><p><blockquote><b>Novavax的收入预测：20亿至80亿美元</b></blockquote></p><p><b>Taylor Carmichael(Novavax):</b>Novavax is on the verge of greatness this year. The company&#39;s stock price is down to $125 a share. That&#39;s where it started in 2021, so last year was pretty much a washout for the stock.</p><p><blockquote><b>泰勒·卡迈克尔（Novavax）：</b>Novavax今年正处于伟大的边缘。该公司的股价跌至每股125美元。这就是它在2021年开始的地方，所以去年该股几乎遭受了洗盘。</blockquote></p><p>Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.</p><p><blockquote>早在2月份，当Novavax报告其新冠疫苗的积极3期数据时，股价就飙升至300美元以上。但后来这家小型生物技术公司遇到了制造问题。虽然许多人说它的疫苗是同类产品中最好的，但扩大约20亿剂疫苗的合同生产说起来容易做起来难。这些现实导致该股较高点下跌约60%。</blockquote></p><p>Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it&#39;s highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company&#39;s already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.</p><p><blockquote>尽管如此，Novavax的收入已经达到了10亿美元大关，因此由于所有的预订，其疫苗甚至在获得批准之前就已经一鸣惊人。现在，全球各地的授权纷至沓来，Novavax很有可能在2022年运送大量疫苗。该公司已经实现了每月1亿剂的生产能力，即一年12亿剂。在第三季度收益看涨期权上，管理层预测到第四季度末将达到每月1.5亿剂（或每年18亿剂）的生产能力。该公司预计将继续扩大规模，并预测2022年将分发20亿剂疫苗。</blockquote></p><p>Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that&#39;s over $4 billion in sales, just in Europe.</p><p><blockquote>20亿剂疫苗，价格为16美元（曲速行动支付了16亿美元预购了1亿剂疫苗），我们粗略计算出收入为320亿美元。当然，Novavax将以较低的速度向发展中国家分发大量疫苗。尽管该公司对其价格保持沉默，但丹麦早在8月份就表示，根据欧盟(EU)协议，它为每剂疫苗支付了近21美元。欧盟已经订购了2亿剂，因此仅在欧洲的销售额就超过40亿美元。</blockquote></p><p></p><p>Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company&#39;s market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.</p><p><blockquote>分析师非常保守，对Novavax 2022年的预测在20亿至80亿美元之间。（该公司的市值为90亿美元。）虽然一路上可能会出现一些问题，但Novavax肯定会在2022年从其COVID-19疫苗中赚取数十亿美元。如果该公司确实像其所说的那样交付20亿剂疫苗，该股可能会有大幅上涨空间。</blockquote></p><p><b>The antibody market all to itself</b></p><p><blockquote><b>抗体市场全靠自己</b></blockquote></p><p><b>Patrick Bafuma(Vir Biotechnology):</b>The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from <b>Eli Lilly</b> (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from <b>Roche</b>and<b>Regeneron</b> are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--<b>GlaxoSmithKline</b> and Vir Biotechnology&#39;s sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it&#39;s the only one left right now to fight the omicron variant.</p><p><blockquote><b>Patrick Bafuma（Vir Biotechnology）：</b>奥密克戎变种目前猖獗，这一次，我们缺少一些治疗方法。以前青睐的单克隆抗体治疗来自<b>礼来公司</b>（bamlanivimab加etesevimab）以及来自<b>罗氏</b>和<b>再生</b>被认为对当前变体的活性显著降低。这样就只剩下一种对奥密克戎有效的输液了--<b>葛兰素史克</b>以及Vir Biotechnology的sotrovimab。这种单克隆抗体先前证明，在轻度至中度新冠肺炎和进展为重度疾病的高风险成人中，住院和死亡风险降低了79%。它是目前唯一一个对抗奥密克戎变种的人。</blockquote></p><p>Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly&#39;s antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.</p><p><blockquote>作为唯一的单克隆抗体将有其特权。2021年前9个月，REGEN-COV带来了35亿美元的产品净销售额，而礼来公司的抗体组合带来了11.7亿美元。美国政府已经签订了价值约10亿美元的sotrovimab合同。随着医院挤满了病人，任何有助于缓解系统压力的东西都可能受到高度追捧。</blockquote></p><p>And while Pfizer&#39;s Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who&#39;s who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid&#39;s possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.</p><p><blockquote>虽然辉瑞的Paxlovid将极大地有利于减轻医疗保健系统的COVID-19负担，但这种口服药物具有显着且复杂的药物相互作用潜力。事实上，它的相互作用列表读起来就像是常用处方药的名人录。这包括流行的血液稀释剂，如波立维和Xarelto，常见的止痛药，如曲马多和羟考酮，抗焦虑药，如Klonopin和Xanax，以及抗胆固醇他汀类药物。随着美国国立卫生研究院发表声明，表达了对Paxlovid可能的药物相互作用的担忧，这为sotrovimab继续广泛使用留下了充足的空间。根据与GSK的协议，Vir获得了sotrovimab销售额的72.5%，这家价值44亿美元的生物技术公司目前看起来很划算。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VIR":"Vir Biotechnology, Inc.","NVAX":"诺瓦瓦克斯医药","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2022/01/07/3-covid-stocks-that-will-make-billions-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134509683","content_text":"It's a new year and COVID-19 is still with us. Last year we saw Emergency Use Authorizations for multiple COVID vaccines and treatments across the healthcare space. Pharmaceutical companies are set to make billions of dollars in 2022. Here are three stocks that should thrive.Pfizer(NYSE:PFE), the $310 billion mega cap, is expected to bring in not $1 billion or $10 billion but over $50 billion in sales for its COVID vaccine and antiviral pill. Scrappy Novavax(NASDAQ:NVAX)is finally introducing its COVID vaccine around the world. How many billions will it receive? And we have a dark horse candidate in Vir Biotechnology(NASDAQ:VIR). It has a drug that could easily be a $1 billion blockbuster for the tiny biotech.IMAGE SOURCE: GETTY IMAGES.A safe harbor in stormy weatherGeorge Budwell(Pfizer):Pfizer is the undisputed champion of COVID-19 pharmaceutical products. In 2022 alone, Wall Street expects the pharma giant to rake in $55 billion in sales between its novel coronavirus vaccine, Comirnaty, and its oral antiviral pill, Paxlovid.What's more, analysts are starting to warm up to the idea that Paxlovid might be a sustainable revenue generator for the company over the course of the current decade. When the drug was first allowed on the market by the Food and Drug Administration under the Emergency Use Authorization pathway last month, Wall Street thought Paxlovid would likely peak from a commercial standpoint within a year or so, and then experience a dramatic drop in sales as the pandemic faded from view.But less than three weeks out from the drug's initial approval, it is becoming painfully obvious that Paxlovid will probably be required as a fail-safe against the worst outcomes from COVID-19 for several more years. The highly infectious omicron variant, after all, will certainly not be the last major iteration of the virus.What this all means is that Pfizer ought to be one of the few large-cap drugmakers with a sizable, long-term COVID-19 revenue source. Pfizer, in turn, should have ample free cash flows to feed its generous shareholder reward program, as well as its ambitious business development plans, for the foreseeable future.So, if you're looking for a stock that can weather the dual headwinds of sky-high inflation and rising interest rates, Pfizer might be worth checking out.Revenue forecasts for Novavax:  $2 billion to $8 billionTaylor Carmichael(Novavax):Novavax is on the verge of greatness this year. The company's stock price is down to $125 a share. That's where it started in 2021, so last year was pretty much a washout for the stock.Back in February the share price zoomed over $300 when Novavax reported positive phase 3 data for its COVID vaccine. But then the small biotech ran into manufacturing issues. While its vaccine is said by many to be the best in class, scaling up the contract manufacturing for an estimated 2 billion doses of vaccine is easier said than done. And those realities have caused the stock to drop about 60% off its highs.Nonetheless, Novavax has already hit the $1 billion revenue mark, so its vaccine was a blockbuster even before it was approved, because of all the preorders. Now that authorizations are pouring in from around the globe, it's highly likely that Novavax will ship a massive number of vaccine doses in 2022. The company's already achieved a manufacturing capacity of 100 million doses a month, or 1.2 billion doses in a year. On the third-quarter earnings call, management predicted it would reach a manufacturing capacity of 150 million doses every month (or 1.8 billion doses a year) by the end of the fourth quarter. And the company expects to continue to scale and forecasts that it will distribute 2 billion doses in 2022.Two billion doses of vaccine, at a price point of $16 (Operation Warp Speed paid $1.6 billion to pre-order 100 million doses) gives us a back-of-the-envelope calculation of $32 billion in revenue. Of course, Novavax will be distributing a lot of vaccines to the developing world at a reduced rate. While the company has been quiet about its prices, Denmark said back in August that it paid almost $21 a dose under the European Union (EU) agreement. The EU has ordered 200 million doses, so that's over $4 billion in sales, just in Europe.Analysts are being extremely conservative, with a forecast ranging from $2 billion to $8 billion for Novavax in 2022. (The company's market cap sits at $9 billion.) While there may be hiccups along the way, Novavax is sure to make billions of dollars off its COVID-19 vaccine in 2022. And there could be significant upside to the stock if the company does indeed deliver 2 billion doses as it says it will.The antibody market all to itselfPatrick Bafuma(Vir Biotechnology):The omicron variant is currently running rampant, and this time, we are short a few treatments. Previously favored monoclonal antibody treatments from Eli Lilly (bamlanivimab plus etesevimab) as well as the REGEN-COV cocktail from RocheandRegeneron are believed to have marked diminished activity against the current variant. This leaves a single infusiont hought to be active against omicron--GlaxoSmithKline and Vir Biotechnology's sotrovimab. This monoclonal antibody previously demonstrated a reduced risk of hospitalization and death by 79% in adults with mild to moderate COVID-19 and at high risk of progression to severe disease. And it's the only one left right now to fight the omicron variant.Being the sole monoclonal antibody on the block will have its privileges. Through the first nine months of 2021, REGEN-COV brought in $3.5 billion in net product sales, while Eli Lilly's antibody combination brought in $1.17 billion. The U.S. government has already contracted for approximately $1 billion worth of sotrovimab. With hospitals overflowing with patients, anything that can help alleviate some of the stress on the system is likely going to be highly sought after.And while Pfizer's Paxlovid will be hugely beneficial to ease the COVID-19 burden on the healthcare system, the oral medication has significant and complex drug-drug interaction potential. In fact, its interaction list reads like a who's who of commonly prescribed medications. This includes popular blood thinning agents such as Plavix and Xarelto, common analgesics like Tramadol and oxycodone, anxiolytics like Klonopin and Xanax, as well as cholesterol-fighting statins. With the National Institutes of Health issuing a statement voicing its concern over Paxlovid's possible drug interactions, this leaves plenty of room for sotrovimab to continue to be widely prescribed. With Vir getting 72.5% of sotrovimab sales per its agreement with GSK, the $4.4 billion biotech looks like a bargain right now.","news_type":1,"symbols_score_info":{"VIR":0.9,"PFE":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693004175,"gmtCreate":1639920131883,"gmtModify":1639920132008,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693004175","repostId":"2192903248","repostType":4,"isVote":1,"tweetType":1,"viewCount":996,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":695784326,"gmtCreate":1641601075110,"gmtModify":1641601075405,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Wow I see ok!","listText":"Wow I see ok!","text":"Wow I see ok!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/695784326","repostId":"2201216295","repostType":4,"isVote":1,"tweetType":1,"viewCount":3216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":695596823,"gmtCreate":1641510812466,"gmtModify":1641510812589,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Wow!","listText":"Wow!","text":"Wow!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/695596823","repostId":"1166118266","repostType":4,"repost":{"id":"1166118266","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641482074,"share":"https://www.laohu8.com/m/news/1166118266?lang=zh_CN&edition=full","pubTime":"2022-01-06 23:14","market":"us","language":"en","title":"WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%<blockquote>WSB股价早盘暴跌，Micovision下跌近12%，AMC下跌超过6%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1166118266","media":"Tiger Newspress","summary":"WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%.","content":"<p><html><head></head><body>WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%.<img src=\"https://static.tigerbbs.com/c60f40de514ea1491fcc1b628923f44f\" tg-width=\"282\" tg-height=\"435\" referrerpolicy=\"no-referrer\"/>On Wednesday, the Federal Reserve released minutes from its December meeting. While officials had already announced a tapering of bond purchases and expectations for several rate hikes this year, the minutes revealed the possibility for even more aggressive moves. Several officials thought the Fed could shrink its balance sheet of Treasuries and mortgage-backed assets, which it has been buying for some time to nurse the economy back to health. Tapering asset purchases merely suggested the Fed would be buying fewer securities but would still be purchasing. Letting the balance sheet shrink would be an indicator of even tighter financial conditions than that.</p><p><blockquote><html><head></head><body>WSB股价早盘暴跌，Micovision下跌近12%，AMC下跌超过6%。周三，美联储公布了12月会议纪要。尽管官员们已经宣布缩减购债规模，并预计今年将多次加息，但会议纪要显示，可能会采取更激进的举措。几位官员认为，美联储可能会缩减其国债和抵押贷款支持资产的资产负债表，美联储购买这些资产已经有一段时间了，以帮助经济恢复健康。缩减资产购买只是表明美联储将减少购买证券，但仍将继续购买。让资产负债表收缩将表明金融状况比这更紧张。</body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%<blockquote>WSB股价早盘暴跌，Micovision下跌近12%，AMC下跌超过6%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%<blockquote>WSB股价早盘暴跌，Micovision下跌近12%，AMC下跌超过6%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2022-01-06 23:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%.<img src=\"https://static.tigerbbs.com/c60f40de514ea1491fcc1b628923f44f\" tg-width=\"282\" tg-height=\"435\" referrerpolicy=\"no-referrer\"/>On Wednesday, the Federal Reserve released minutes from its December meeting. While officials had already announced a tapering of bond purchases and expectations for several rate hikes this year, the minutes revealed the possibility for even more aggressive moves. Several officials thought the Fed could shrink its balance sheet of Treasuries and mortgage-backed assets, which it has been buying for some time to nurse the economy back to health. Tapering asset purchases merely suggested the Fed would be buying fewer securities but would still be purchasing. Letting the balance sheet shrink would be an indicator of even tighter financial conditions than that.</p><p><blockquote><html><head></head><body>WSB股价早盘暴跌，Micovision下跌近12%，AMC下跌超过6%。周三，美联储公布了12月会议纪要。尽管官员们已经宣布缩减购债规模，并预计今年将多次加息，但会议纪要显示，可能会采取更激进的举措。几位官员认为，美联储可能会缩减其国债和抵押贷款支持资产的资产负债表，美联储购买这些资产已经有一段时间了，以帮助经济恢复健康。缩减资产购买只是表明美联储将减少购买证券，但仍将继续购买。让资产负债表收缩将表明金融状况比这更紧张。</body></html></blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","MVIS":"维视图像"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166118266","content_text":"WSB Stocks Tumbled in Morning Trading, with Micovision Slipping Nearly 12% and AMC Slipping Over 6%.On Wednesday, the Federal Reserve released minutes from its December meeting. While officials had already announced a tapering of bond purchases and expectations for several rate hikes this year, the minutes revealed the possibility for even more aggressive moves. Several officials thought the Fed could shrink its balance sheet of Treasuries and mortgage-backed assets, which it has been buying for some time to nurse the economy back to health. Tapering asset purchases merely suggested the Fed would be buying fewer securities but would still be purchasing. Letting the balance sheet shrink would be an indicator of even tighter financial conditions than that.","news_type":1,"symbols_score_info":{"MVIS":0.9,"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":2769,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692248164,"gmtCreate":1641007210279,"gmtModify":1641007334497,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692248164","repostId":"2200744536","repostType":4,"isVote":1,"tweetType":1,"viewCount":3230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":692248347,"gmtCreate":1641007195112,"gmtModify":1641007334405,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692248347","repostId":"1114332157","repostType":4,"isVote":1,"tweetType":1,"viewCount":4452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698746263,"gmtCreate":1640565094403,"gmtModify":1640565094496,"author":{"id":"4098943201642940","authorId":"4098943201642940","name":"AlfonsoDex","avatar":"https://static.tigerbbs.com/e2cc50e7239df9698053b8beee0555f4","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098943201642940","authorIdStr":"4098943201642940"},"themes":[],"htmlText":"Yes this is a big concern... hope all go well eventually","listText":"Yes this is a big concern... hope all go well eventually","text":"Yes this is a big concern... hope all go well eventually","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698746263","repostId":"2194177763","repostType":2,"repost":{"id":"2194177763","kind":"highlight","pubTimestamp":1640555213,"share":"https://www.laohu8.com/m/news/2194177763?lang=zh_CN&edition=full","pubTime":"2021-12-27 05:46","market":"us","language":"zh","title":"外媒头条：奥密克戎重挫航空旅行！周日数千个航班被取消","url":"https://stock-news.laohu8.com/highlight/detail?id=2194177763","media":"市场资讯","summary":"　　周日，美国数百个航班和全球数千个航班被取消，原因是在今年最繁忙的一个周末，奥密克戎变种病毒导致机组人员患病。　　据提供航空数据的FlightAware称，截至周日中午，至少有一站在美国的750多个航班被取消，而全球航班的取消数字则是其10倍。　　周日的惨淡记录是在圣诞前夜和圣诞节期间全球数千次航班取消之后出现的。取消航班可能会打乱旅行计划，而此时许多人正乘飞机与家人共度圣诞假期。","content":"<p><b>全球财经媒体昨夜今晨共同关注的头条新闻主要有：</b></p>\n<blockquote>\n <b>1、奥密克戎重挫航空旅行 周日全球数千个航班被取消</b>\n</blockquote>\n<blockquote>\n <b>2、疫情下世界各国收紧新年庆典防疫政策 多地取消活动</b>\n</blockquote>\n<blockquote>\n <b>3、福奇警告美国人不要对病毒掉以轻心 医院有可能被挤爆</b>\n</blockquote>\n<blockquote>\n <b>4、英国智库：世界经济规模预计在明年超过100万亿美元</b>\n</blockquote>\n<blockquote>\n <b>5、土耳其颁布新措施救市 里拉短时间内大幅度反弹</b>\n</blockquote>\n<blockquote>\n <b>6、<a href=\"https://laohu8.com/S/MA\">万事达</a>报告称假日销售飙升 电子商务获得巨大收益</b>\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/c3ba1ba0a72a5c08f91ca9cb2fb61ccf\" tg-width=\"550\" tg-height=\"366\" referrerpolicy=\"no-referrer\"></p>\n<p><b>奥密克戎重挫航空旅行 周日全球数千个航班被取消</b></p>\n<p>周日，美国数百个航班和全球数千个航班被取消，原因是在今年最繁忙的一个周末，奥密克戎变种病毒导致机组人员患病。</p>\n<p>据提供航空数据的FlightAware称，截至周日中午，至少有一站在美国的750多个航班被取消，而全球航班的取消数字则是其10倍。</p>\n<p>周日的惨淡记录是在圣诞前夜和圣诞节期间全球数千次航班取消之后出现的。取消航班可能会打乱旅行计划，而此时许多人正乘飞机与家人共度圣诞假期。在美国，这一传统今年似乎有所反弹：根据交通安全管理局（Transportation Security Administration）的数据，上周每天大约有200万人通过安检，而平安夜和圣诞节的人数几乎是去年的两倍。</p>\n<p><img src=\"https://static.tigerbbs.com/b4003025308bf64f066cd7aed5a06db1\" tg-width=\"550\" tg-height=\"291\" referrerpolicy=\"no-referrer\"></p>\n<p><b>疫情下世界各国收紧新年庆典防疫政策 多地取消活动</b></p>\n<p>由于新冠omicron变种的传播，世界各地的大城市正在取消他们的新年庆祝活动，而其他城市正在推进他们的计划。</p>\n<p>纽约市标志性的新年庆祝活动将如期举行，但市长比尔·德布拉<a href=\"https://laohu8.com/S/SIAL\">西奥</a>表示，由于奥密克戎变异病毒的传播，参加派对的人将不得不接受全面接种，戴上口罩，并采取社交疏远措施，活动因此将“缩减规模”。</p>\n<p>这位美国最大城市的市长解释说：“纽约人在过去的一年里取得了巨大的进步——我们在疫苗接种方面处于领先地位，我们已经安全地重新开放，每天我们都在努力为我们所有人建设一个恢复期．．．．．．有很多值得庆祝的事情，这些额外的安全措施将在新年来临之际让接种疫苗的人群保持安全和健康。”</p>\n<p>全球其他城市采取了不同的做法，有的完全取消了庆祝活动。</p>\n<p><img src=\"https://static.tigerbbs.com/c2abf615da9d23bee2f444dbfcb67f75\" tg-width=\"550\" tg-height=\"366\" referrerpolicy=\"no-referrer\"></p>\n<p><b>福奇警告美国人不要对病毒掉以轻心 医院有可能被挤爆</b></p>\n<p>美国总统拜登的首席医学顾问福奇周日表示，尽管迹象表明omicron的症状可能不那么严重，但美国人仍应保持警惕，因为病患数量可能导致医院不堪重负。</p>\n<p>福奇在节目“This Week”上对记者Jonathan Karl说，“我们不希望看到大家掉以轻心，虽然omicron的病症不严重，但出现这么多新确诊病例可能抵消该因素”。</p>\n<p>来自苏格兰的初步数据显示，omicron“带来的住院风险比德尔塔低三分之二”，研究同时也表明，omicron导致二次感染新冠病毒的可能性是德尔塔的10倍左右。</p>\n<p>据报道，美国单日新增omicron感染病例已超过德尔塔病毒感染者，<a href=\"https://laohu8.com/S/AAL\">美国航空</a>企业在长周末假期取消了近1，900个航班，因为病例激增导致工作人员短缺。</p>\n<p><img src=\"https://static.tigerbbs.com/a5dc1c2269bd67acb592df752986ba66\" tg-width=\"550\" tg-height=\"343\" referrerpolicy=\"no-referrer\"></p>\n<p><b>英国智库：世界经济规模预计在明年超过100万亿美元</b></p>\n<p>根据一份预测，2022年世界经济规模势将首次超过100万亿美元，比先前预测的时间提早两年。</p>\n<p>总部位于英国伦敦的经济与商业研究中心（Centre for Economics and Business Research， CEBR）认为，全球国内生产总值（GDP）将受到疫情持续复苏的提振，不过如果通胀持续，决策者可能很难防止经济再度陷入衰退。</p>\n<p>“21世纪20年代的重要问题是全球经济体如何应对通胀，” CEBR副主席Douglas McWilliams表示。 “我们希望能用相对温和的调整来使得非暂时性因素得到控制。如果不这样，那么世界将需要为2023年或2024年的经济衰退做好准备。”</p>\n<p><img src=\"https://static.tigerbbs.com/4fd25fb23bbaab45631729cf6e09db84\" tg-width=\"500\" tg-height=\"333\" referrerpolicy=\"no-referrer\"></p>\n<p><b>土耳其颁布新措施救市 里拉短时间内大幅度反弹</b></p>\n<p>土耳其里拉本周走出一波大幅上涨行情，里拉对美元汇率由20日的18比1左右急速攀升至最高时的10比1左右，最终维持在11比1左右，涨幅逾40%，回到上月中下旬时的水平。</p>\n<p>近期，里拉汇率屡现剧烈波动行情。16日，里拉对美元汇率跌破15比1大关；17日，里拉对美元汇率跌破16和17两个整数关口；20日，里拉对美元汇率跌破18比1大关。本月以来，土耳其<a href=\"https://laohu8.com/S/CNBC\">中央银行</a>已经五次干预外汇市场。</p>\n<p>20日晚，土耳其总统埃尔多安宣布新救市措施，里拉汇率随即一转颓势，大幅上扬并逐渐企稳。救市措施包括一项新的金融替代方案，为本币储蓄因里拉贬值蒙受的损失提供补偿，以减少汇率波动对储户的影响。同时，政府将采取大幅提高个人养老金补贴等措施，以减轻民众生活成本压力。</p>\n<p><img src=\"https://static.tigerbbs.com/9e1d7eff89b4a5234ad828b7dca303d5\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\"></p>\n<p><b>万事达报告称假日销售飙升 电子商务获得巨大收益</b></p>\n<p>根据万事达卡（Mastercard）周日发布的一份报告，与2019年的假日期间相比，美国本季度的零售额增长了近11%。2019年是新冠大流行颠覆全球经济的前一年。</p>\n<p>这份名为Mastercard SpendingPulse的报告显示，与去年相比，在11月1日至12月24日的假日期间，零售销售额增长了8.5%。这些数据不包括汽车销售。</p>\n<p>与去年相比，实体店的销售额增长了8.1%，电子商务销售额增长了11%。与2019年相比，在新冠肺炎疫情导致网上订单激增之前，电子商务销售额增长了61%以上。</p>\n<p>根据万事达卡的报告，今年网上销售占零售总额的20.9%。2019年，在线销售仅占所有零售销售的14.6%，突显出疫情如何加速了向电子商务的转变。</p>\n<p>万事达卡高级顾问史蒂夫·萨多夫在一份声明中表示，许多美国人今年提前完成了圣诞购物。他说：“购物者急于在零售热潮到来之前确保自己的礼物，对供应链和劳动力供应问题的讨论让消费者成群结队地来到网上和商店（进行消费）。”</p>","source":"sina_us","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒头条：奥密克戎重挫航空旅行！周日数千个航班被取消</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒头条：奥密克戎重挫航空旅行！周日数千个航班被取消\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 05:46 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2021-12-27/doc-ikyakumx6577426.shtml><strong>市场资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、奥密克戎重挫航空旅行 周日全球数千个航班被取消\n\n\n2、疫情下世界各国收紧新年庆典防疫政策 多地取消活动\n\n\n3、福奇警告美国人不要对病毒掉以轻心 医院有可能被挤爆\n\n\n4、英国智库：世界经济规模预计在明年超过100万亿美元\n\n\n5、土耳其颁布新措施救市 里拉短时间内大幅度反弹\n\n\n6、万事达报告称假日销售飙升 电子商务获得巨大收益\n\n\n...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-12-27/doc-ikyakumx6577426.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/c2abf615da9d23bee2f444dbfcb67f75","relate_stocks":{"BK4566":"资本集团",".IXIC":"NASDAQ Composite","BK4527":"明星科技股","BK4213":"石油与天然气的勘探与生产","BK4559":"巴菲特持仓","BK4535":"淡马锡持仓","GDP":"古德里奇","BK4548":"巴美列捷福持仓",".SPX":"S&P 500 Index","BK4106":"数据处理与外包服务","BK4533":"AQR资本管理(全球第二大对冲基金)",".DJI":"道琼斯","MA":"万事达"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-12-27/doc-ikyakumx6577426.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194177763","content_text":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、奥密克戎重挫航空旅行 周日全球数千个航班被取消\n\n\n2、疫情下世界各国收紧新年庆典防疫政策 多地取消活动\n\n\n3、福奇警告美国人不要对病毒掉以轻心 医院有可能被挤爆\n\n\n4、英国智库：世界经济规模预计在明年超过100万亿美元\n\n\n5、土耳其颁布新措施救市 里拉短时间内大幅度反弹\n\n\n6、万事达报告称假日销售飙升 电子商务获得巨大收益\n\n\n奥密克戎重挫航空旅行 周日全球数千个航班被取消\n周日，美国数百个航班和全球数千个航班被取消，原因是在今年最繁忙的一个周末，奥密克戎变种病毒导致机组人员患病。\n据提供航空数据的FlightAware称，截至周日中午，至少有一站在美国的750多个航班被取消，而全球航班的取消数字则是其10倍。\n周日的惨淡记录是在圣诞前夜和圣诞节期间全球数千次航班取消之后出现的。取消航班可能会打乱旅行计划，而此时许多人正乘飞机与家人共度圣诞假期。在美国，这一传统今年似乎有所反弹：根据交通安全管理局（Transportation Security Administration）的数据，上周每天大约有200万人通过安检，而平安夜和圣诞节的人数几乎是去年的两倍。\n\n疫情下世界各国收紧新年庆典防疫政策 多地取消活动\n由于新冠omicron变种的传播，世界各地的大城市正在取消他们的新年庆祝活动，而其他城市正在推进他们的计划。\n纽约市标志性的新年庆祝活动将如期举行，但市长比尔·德布拉西奥表示，由于奥密克戎变异病毒的传播，参加派对的人将不得不接受全面接种，戴上口罩，并采取社交疏远措施，活动因此将“缩减规模”。\n这位美国最大城市的市长解释说：“纽约人在过去的一年里取得了巨大的进步——我们在疫苗接种方面处于领先地位，我们已经安全地重新开放，每天我们都在努力为我们所有人建设一个恢复期．．．．．．有很多值得庆祝的事情，这些额外的安全措施将在新年来临之际让接种疫苗的人群保持安全和健康。”\n全球其他城市采取了不同的做法，有的完全取消了庆祝活动。\n\n福奇警告美国人不要对病毒掉以轻心 医院有可能被挤爆\n美国总统拜登的首席医学顾问福奇周日表示，尽管迹象表明omicron的症状可能不那么严重，但美国人仍应保持警惕，因为病患数量可能导致医院不堪重负。\n福奇在节目“This Week”上对记者Jonathan Karl说，“我们不希望看到大家掉以轻心，虽然omicron的病症不严重，但出现这么多新确诊病例可能抵消该因素”。\n来自苏格兰的初步数据显示，omicron“带来的住院风险比德尔塔低三分之二”，研究同时也表明，omicron导致二次感染新冠病毒的可能性是德尔塔的10倍左右。\n据报道，美国单日新增omicron感染病例已超过德尔塔病毒感染者，美国航空企业在长周末假期取消了近1，900个航班，因为病例激增导致工作人员短缺。\n\n英国智库：世界经济规模预计在明年超过100万亿美元\n根据一份预测，2022年世界经济规模势将首次超过100万亿美元，比先前预测的时间提早两年。\n总部位于英国伦敦的经济与商业研究中心（Centre for Economics and Business Research， CEBR）认为，全球国内生产总值（GDP）将受到疫情持续复苏的提振，不过如果通胀持续，决策者可能很难防止经济再度陷入衰退。\n“21世纪20年代的重要问题是全球经济体如何应对通胀，” CEBR副主席Douglas McWilliams表示。 “我们希望能用相对温和的调整来使得非暂时性因素得到控制。如果不这样，那么世界将需要为2023年或2024年的经济衰退做好准备。”\n\n土耳其颁布新措施救市 里拉短时间内大幅度反弹\n土耳其里拉本周走出一波大幅上涨行情，里拉对美元汇率由20日的18比1左右急速攀升至最高时的10比1左右，最终维持在11比1左右，涨幅逾40%，回到上月中下旬时的水平。\n近期，里拉汇率屡现剧烈波动行情。16日，里拉对美元汇率跌破15比1大关；17日，里拉对美元汇率跌破16和17两个整数关口；20日，里拉对美元汇率跌破18比1大关。本月以来，土耳其中央银行已经五次干预外汇市场。\n20日晚，土耳其总统埃尔多安宣布新救市措施，里拉汇率随即一转颓势，大幅上扬并逐渐企稳。救市措施包括一项新的金融替代方案，为本币储蓄因里拉贬值蒙受的损失提供补偿，以减少汇率波动对储户的影响。同时，政府将采取大幅提高个人养老金补贴等措施，以减轻民众生活成本压力。\n\n万事达报告称假日销售飙升 电子商务获得巨大收益\n根据万事达卡（Mastercard）周日发布的一份报告，与2019年的假日期间相比，美国本季度的零售额增长了近11%。2019年是新冠大流行颠覆全球经济的前一年。\n这份名为Mastercard SpendingPulse的报告显示，与去年相比，在11月1日至12月24日的假日期间，零售销售额增长了8.5%。这些数据不包括汽车销售。\n与去年相比，实体店的销售额增长了8.1%，电子商务销售额增长了11%。与2019年相比，在新冠肺炎疫情导致网上订单激增之前，电子商务销售额增长了61%以上。\n根据万事达卡的报告，今年网上销售占零售总额的20.9%。2019年，在线销售仅占所有零售销售的14.6%，突显出疫情如何加速了向电子商务的转变。\n万事达卡高级顾问史蒂夫·萨多夫在一份声明中表示，许多美国人今年提前完成了圣诞购物。他说：“购物者急于在零售热潮到来之前确保自己的礼物，对供应链和劳动力供应问题的讨论让消费者成群结队地来到网上和商店（进行消费）。”","news_type":1,"symbols_score_info":{".DJI":0,"GDP":0,".IXIC":0,"MA":0,".SPX":0}},"isVote":1,"tweetType":1,"viewCount":3920,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}